catheter ablation - search results

If you're not happy with the results, please do another search
ablation

Catheter ablation “economically attractive” compared to drug therapy for AF

Catheter ablation of atrial fibrillation (AF) was economically attractive compared with drug therapy in the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial...

AF Symposium 2022: Latest evidence for lattice tip catheter ablation strategies shared

Pulsed-field ablation (PFA) and/or radiofrequency ablation (RFA) using a lattice-tip catheter can both isolate pulmonary veins (PVs) and create linear lesions efficiently and safely,...
ablation

Same-day discharge for catheter ablation of atrial fibrillation deemed safe and feasible

A recent systematic review and meta-analysis, published in the Journal of Interventional Cardiac Electrophysiology, has deemed same-day discharge following catheter ablation of atrial fibrillation...

HRS 2021: CABANA analysis points to economic case for catheter ablation

A new analysis of the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation) suggests that catheter ablation offers positive economic outcomes compared...

HRS 2021: Early VT catheter ablation beats medical therapy in patients at risk for...

Results of the PAUSE-SCD trial show a significant reduction in risk of ventricular tachycardia (VT) recurrence, cardiovascular hospitalisation, and death when catheter ablation is...

CABANA trial shows favourable results for catheter ablation among ethnic minority patients

Among racial or ethnic minority patients enrolled in the North American cohort of the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation)...

AHA statement on AF and HFrEF positive for catheter ablation

The American Heart Association (AHA) has this week issued a scientific statement on the management of atrial fibrillation (AF) in patients with heart failure...

AF Symposium 2021: HARTCAP-AF supports hybrid over catheter ablation

Hybrid ablation, a procedure which involves “attacking” the atrial substrate from the epicardium and endocardium, has been shown to result in significantly higher freedom...

AF Symposium 2021: Hybrid, multidisciplinary therapy superior to catheter ablation for long-standing persistent AF

Results of a sub-analysis of the CONVERGE clinical trial, presented during a late-breaking trial session at the digital AF Symposium (29–31 January, virtual), suggest...

Catheter ablation linked to lower incidence of dementia in AF patients

People with atrial fibrillation (AF) have a reduced risk of dementia if they undergo catheter ablation to restore the normal rhythm of their heart,...

Paper highlights use of robotic system for catheter ablation in COVID-19 patients

Stereotaxis has announced the publication of a paper in the European Heart Journal highlighting the benefits of using robotic technology for the management of...

Virtual ACC: Ethanol infusion in vein of Marshall improves catheter ablation outcomes 

The infusion of ethanol via the vein of Marshall (VOM), coupled with catheter ablation, leads to improved outcomes for patients with persistent atrial ablation, according to the findings of a study presented by...

Tackling focal VT may improve catheter ablation in structural heart disease

Uncovering and abolishing focal ventricular tachycardia (VT) may further improve outcomes of catheter ablation in the treatment of structural heart disease, a study published...
atrial fibrillation

ESC 2019: Catheter ablation may be up to 10 times more effective than drug...

Results from the Atrial fibrillation progression trial (ATTEST) were presented on 31 August at the European Society of Cardiology (ESC) Congress 2019 in Paris,...
New ESC guidelines on SVTs

ESC 2019: Guidelines on supraventricular tachycardias underline pivotal role of catheter ablation

The European Society of Cardiology (ESC) unveiled guidelines for treatment of supraventricular tachycardia (SVT) on the opening day of its Congress (ESC 2019; 31...
Cardiac Rhythm news for specialists

Biomarkers may predict AF after catheter ablation

Researchers have identified a combination of serum biomarkers that is independently associated with higher prevalence of atrial fibrillation, and with increased incidence and recurrence...

New guidelines for cardiovascular disease management during pregnancy: Risk-dependent action plans and upgraded recommendations...

New guidelines for the management of cardiovascular diseases during pregnancy, including upgraded recommendations of catheter ablation and risk-dependent action plans, were presented by Carina...

Thoracoscopic ablation and left atrial appendage excision found to be superior to catheter ablation...

Symptomatic atrial fibrillation (AF) patients with previous failed catheter ablation or structural changes associated with higher recurrence of AF could benefit from thoracoscopic ablation...
atrial fibrillation

Surgical treatment of atrial fibrillation results in higher complication rates when compared to catheter...

The total procedure-related complications after surgical minimally invasive pulmonary vein isolations (MIPI) were higher; this was mainly due to more major complications. During a...

Apixaban is a safe alternative to warfarin during catheter ablation of atrial fibrillation and...

Apixaban and warfarin are equally safe during catheter ablation of atrial fibrillation, according to results of the AXAFA-AFNET 5 (Anticoagulation using the direct factor...

Catheter ablation for atrial fibrillation: Lessons and developments

It was a year of big results for catheter ablation, continuing the procedure’s steady rise in atrial fibrillation (AF) management. Mark O’Neill, consultant cardiologist...
Cardiac Rhythm news for specialists

Results of CASTLE-AF trial published: catheter ablation better than conventional drug therapy for atrial...

The results of the CASTLE-AF study, published today in the New England Journal of Medicine, show that patients treated with radiofrequency catheter ablation rather than...

Measuring outcomes after catheter ablations for AF

Published in the Journal of the American College of Cardiology (JACC): Clinical Electrophysiology, Björkenheim et al’s study of patient- and physician-reported outcomes of atrial...

Catheter ablation lowers mortality in atrial fibrillation patients with heart failure

Catheter ablation of atrial fibrillation significantly reduces mortality and hospitalisation in atrial fibrillation patients with heart failure in comparison with conventional treatment, data from...
Cardiac Rhythm news for specialists

21st Prague Workshop on Catheter Ablation

W: www.ablationworkshop.com

Catheter ablation is superior to amiodarone in the treatment of patients with heart failure...

New research indicates that catheter ablation may achieve greater long-term freedom from atrial fibrillation, as well as a reduction in unplanned hospitalisation and mortality...

Radiofrequency catheter ablation shows benefits for recurrent ventricular tachycardia patients

A prospective, multicentre study—THERMOCOOL VT—analysing a cohort of non-randomised patients, published in February in the Journal of the American College of Cardiology, has shown...

Catheter ablation superior to amiodarone for patients with persistent atrial fibrillation and heart failure

Speaking at the 2015 American College of Cardiology Annual Scientific Session, Luigi Di Biase reported that-compared with the antiarrhythmic drug amiodarone-catheter ablation significantly increases the rate of freedom of recurrence in patients with persistent atrial fibrillation and heart failure.

Ventricular tachycardia treatment with robotic catheter ablation shows positive results

A study undertaken in the UK has shown that radiofrequency ablation of scar-related ventricular tachycardia, using robotic navigation, is safe and feasible and has resulted in 95% reduction in total implantable cardioverter defibrillator (ICD) therapy burden at six months.

The challenge of catheter ablation in congenital heart disease patients

Dominic Abrams (Division of Cardiac Electrophysiology, Boston Children's Hospital, Boston, USA) writes on the importance of arrhythmia management in congenital heart disease patients and identifies the reasons why it remains a major challenge for interventional eletrophysiology.
Cardiac Rhythm news for specialists

Population-based study confirms radiofrequency catheter ablation as safe and effective in paediatric patients

A new population-based study confirms previous study reports that radiofrequency catheter ablation is a safe method of arrhythmia treatment in children with long-term cumulative efficacy exceeding 90%, and a highly significant decrease in the procedure and fluoroscopy time during the study period.

First Latin American registry of catheter ablation of cardiac arrhythmias

Luis Aguinaga and Roberto Keegan give an overview on the design and initial results of the first Latin American catheter ablation of cardiac arrhythmias registry led by the Latin American Society of Electrophysiology and Cardiac Stimulation (SOLAECE).
Cardiac Rhythm news for specialists

Insights into BERLIN study of catheter ablation for ventricular tachycardia treatment

The BERLIN study is a prospective, multicentre study that seeks to determine the best time for catheter ablation in the treatment of patients with sustained ventricular tachycardia and coronary artery disease.
Cardiac Rhythm news for specialists

Catheter ablation may reduce stroke risk in atrial fibrillation patients

A first of its kind study has shown that patients with atrial fibrillation who undergo catheter ablation have a lower stroke risk than patients who do not undergo the procedure independent of CHADS2 score.

Idiopathic ventricular tachycardia: transcatheter ablation or antiarrhythmic drugs?

Claudio Tondo (Milan, Italy) analyses the best treatment options for different kinds of idiopathic ventricular tachycardias. He will be talking about this subject at Venice Arrhythmias (27-29 October, Venice Italy).
Cardiac Rhythm news for specialists

AlluraClarity reduces radiation in image-guided catheter ablation trial in The Netherlands

The Catharina Hospital (Eindhoven, The Netherlands) and Royal Philips has announced the results of a clinical study involving the treatment of 136 patients with complex heart rhythm disorders such as atrial fibrillation.

How to prevent complications of catheter ablation for atrial fibrillation

John D Day (Murray, USA) has performed more than 3,000 catheter ablation for atrial fibrillation procedures. Based on his experience, he describes five basic principles to minimise the risk of serious complications.
Cardiac Rhythm news for specialists

EFFICAS I study yields new contact force guidelines in catheter ablation treatment of AF

Results from the EFFICAS I, a prospective multicentre study sponsored by Endosense, have led to the development of guidelines for target and minimum contact force, as well as minimum force time integral, during the catheter ablation treatment of paroxysmal atrial fibrillation.
Cardiac Rhythm news for specialists

Successful catheter ablation may reduce total mortality

A study recently published in EP Europace has shown that successful catheter ablation of atrial fibrillation may reduce the risk of total mortality, cardiovascular mortality and total vascular events in patients with an increased risk of stroke.
Cardiac Rhythm news for specialists

Endosense secures US$40.3 million series c financing to advance cardiac arrhythmias treatment with catheter...

Proceeds will be used to support commercialisation of the recently European introduction of the third-generation TactiCath Quartz force-sensing catheter; development of next generation products; completion of the TOCCASTAR investigational device exemption clinical study follow-up and FDA approval submission for the TactiCath.
Cardiac Rhythm news for specialists

Catheter ablation can be performed safely while a patient is on uninterrupted warfarin

Stephen Page and Richard Schilling, St Bartholomew's Hospital, UK, explain why catheter ablation can be performed safely in most patients with uninterrupted warfarin.
Cardiac Rhythm news for specialists

Radiofrequency catheter ablation is safe and effective in the octogenarian patient with atrial fibrillation

A study published in the Journal of Cardiovascular Electrophysiology shows that catheter ablation of octogenarians with atrial fibrillation is as safe and effective as catheter ablation of atrial fibrillation in younger patients
Cardiac Rhythm news for specialists

Catheter ablation of ventricular tachycardia in patients with ARVD/C significantly reduces the burden of...

A new study, published in Circulation: Arrhythmia and Electrophysiology, indicates that catheter ablation of ventricular tachycardia is an important treatment option in patients with ARVD/C, despite a high rate of ventricular tachycardia recurrence, because it reduces the burden of the arrhythmia
Cardiac Rhythm news for specialists

Surgical ablation is more effective but has more procedure-related adverse events than catheter ablation

A trial, simultaneously published online in Circulation and presented at the annual scientific sessions of the American Heart Association (AHA; 12-16 November, Orlando, Florida) has found that minimally invasive surgical ablation is more effective than catheter ablation but is also associated with more procedure-related adverse events
Cardiac Rhythm news for specialists

Gender does not affect periprocedural complications or long-term results of catheter ablation

Despite influencing the epidemiology, pathology, and clinical presentation of cardiac arrhythmias, gender does not appear to affect periprocedural complications and outcomes of catheter ablation, according to a study presented by Sonia Ammar, Munich, Germany at EHRA-Europace in Madrid, Spain.
Cardiac Rhythm news for specialists

Endosense and GE Healthcare sign joint development agreement to improve catheter ablation procedures

The agreement will integrate the contact-force data provided by Endosense into GE's CardioLab electrophysiology recording and Innova imaging platforms.
Cardiac Rhythm news for specialists

Symptoms and quality of life improved with catheter ablation in AF patients

Patients who were treated with catheter ablation reported fewer symptoms and improved quality of life than patients treated with anti-arrhythmia drugs at one year.
Cardiac Rhythm news for specialists

Paroxysmal and non-paroxysmal AF patients benefit from repeat catheter ablation

Isolation of the pulmonary vein antrum and the superior vena cava using intracardiac echocardiography and circular mapping can achieve encouraging cure rates.

Cost-effectiveness of atrial fibrillation catheter ablation

Panos E Vardas, president of the European Heart Rhythm Association, analyses the trend on expanding the existing indications and usage of ablation.
Cardiac Rhythm news for specialists

Mixed evidence on use of radiofrequency catheter ablation for AF

Report funded by the US Agency for Healthcare Research and Quality calls for more research on the effect of catheter ablation on quality of life.
Cardiac Rhythm news for specialists

Mayo Clinic receives US$48 million in grants to study catheter ablation for AF

The CABANA trial is designed to determine whether catheter ablation is more effective than drug therapy for the treatment of atrial fibrillation.
Cardiac Rhythm news for specialists

Expert consensus statement on the catheter ablation of ventricular arrhythmias is released

State-of-the-art review of catheter ablation of VT by an international panel of experts was released during the Heart Rhythm Society's 30th Annual Scientific Sessions.
Cardiac Rhythm news for specialists

One in 1,000 risk of death from catheter ablation for AF

Analysis of data from 162 centres worldwide between 1995 and 2006 showed that tamponade caused the highest number of fatalities, followed by stroke and atrioesophageal fistula.

Freezor cardiac cryoablation catheters approved to treat paediatric AVNRT

Medtronic has announced that the Freezor and Freezor Xtra cardiac cryoablation catheters are approved by the US Food and Drug Administration (FDA) to treat...

First post-approval procedures performed using Heliostar balloon ablation catheter

Biosense Webster, part of the Johnson & Johnson Medical Devices Companies has announced post-approval procedures were successfully performed with the Heliostar radiofrequency balloon ablation...
Medtronic's Arctic Front Advance cryoballoon

Expanded FDA approval for Medtronic’s Arctic Front cryoablation catheter

Medtronic has received US Food and Drug Administration (FDA) expanded approval for the Arctic Front family of cardiac cryoablation catheters for the treatment of...

Galaxy Medical and Japan Lifeline enter distribution agreement for pulsed electric field focal ablation...

Galaxy Medical (Galaxy) and Japan Lifeline (JLL) have announced an exclusive distribution agreement for the ALPHA1 ablation catheter in the USA, developed by Japan...

Biotronik receives CE mark for AICath Force ablation catheter

Biotronik has announced CE mark approval for the AlCath Force the gold-tipped force sensing ablation catheter system. The AlCath Force was designed specifically to show...

US FDA approves Biosense Webster’s Thermocool Smarttouch SF ablation catheter

Johnson & Johnson Medical Devices Companies has announced the US Food and Drug Administration (FDA) approval of Biosense Webster’s Thermocool Smarttouch SF ablation catheter...

Biosense Webster receives CE mark approval for QDot Micro ablation catheter

Johnson & Johnson Medical Devices has today announced European CE mark approval of Biosense Webster’s QDot Micro radiofrequency (RF) ablation catheter. According to a press...

Adagio Medical reports pre-clinical success combining cryoablation catheter with pulsed field ablation

Adagio Medical, developer of the intelligent Continuous Lesion Ablation System (iCLAS), has announced successful pre-clinical results demonstrating its existing cryoablation catheter is also capable...

Durablate catheter results demonstrate feasibility in VT ablation

Thermedical has announced that results from a first-in-human early feasibility study (EFS) using the Durablate catheter to treat ventricular tachycardia (VT) were presented in...

Contact force sensing catheters “safe and effective” in persistent AF ablation

Contact force (CF) sensing catheters have been shown to be safe and effective in persistent atrial fibrillation (AF) ablation, according to the findings of...
Vivek Reddy

Novel lattice tip catheter safe, feasible, and durable in RF ablation

Rapid high-current, temperature-controlled point-by-point pulmonary vein isolation (PVI) and linear ablation has been shown to be clinically feasible and safe in a first-in-human study...

First-in-human study demonstrates safety and efficacy of QDOT MICRO ablation catheter

Data presented at Heart Rhythm 2019 (8–11 May, San Francisco, USA) and published in JACC: Clinical Electrophysiology indicates that the QDOT MICRO (Biosense Webster),...

First AF patient treated in US IDE study evaluating QDot Micro RF ablation catheter

It was recently announced that Biosense Webster has enrolled and treated the first patient in its US Investigational Device Exemption (IDE) study, which evaluates...

First patient treated in STELLAR US study evaluating next-generation balloon ablation catheter for atrial...

Biosense Webster has enrolled and treated the first patient in its STELLAR US investigational device exemption (IDE) study. The study will evaluate the safety...

Adagio Medical treats first atrial fibrillation patients using new One Shot+ cryoablation catheter

Adagio Medical, the developer of the iCLAS technology—the company's ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias—announces that the...

US Patent Office allows AblaCor five ablation catheter-anchoring patents

AblaCor medical corporation has announced that it has received a notice of allowance from the United States Patent & Trademark Office on five additional patents for...

Medtronic initiates global trial of Arctic Front Advance cardiac cryoablation catheter

Medtronic has enrolled the first participants in the STOP Persistent AF clinical trial. The trial will evaluate the safety and effectiveness of a pulmonary...

US FDA approves expanded indication for Medtronic Freezor Xtra cryoablation catheter

The US Food and Drug Administration (FDA) has approved Medtronic’s Freezor Xtra cryoablation catheter for treating patients with atrioventricular nodal re-entrant tachycardia (AVNRT). The...

Osypka AG launches 8mm gold-tipped Cerablate Flutter ablation catheter

According to a company release, the new device is ideal for maximum voltage guided ablation of atrial flutter. The Cerablate Flutter is a newly designed...

First patient enrolled in the GOLD AF registry of Medtronic’s PVAC Gold ablation catheter

Medtronic has announced the first patient enrolment in the GOLD AF registry, a first-of-its-kind, prospective, observational clinical study of its Phased Radiofrequency (RF) Ablation technology for treating patients with symptomatic atrial fibrillation.

St Jude Medical announces FDA approval of FlexAbility Ablation Catheter

The FlexAbility catheter features a handle and shaft combination that allows for improved maneuverability, enabling electrophysiologists to reach challenging anatomic locations within their patients' hearts.

St Jude Medical receives FDA approval of TactiCath Quartz Contact Force Ablation Catheter

St Jude Medical has announced the US Food and Drug Administration (FDA) approval of its TactiCath Quartz irrigated ablation catheter, the company's newest technology that gives physicians a real-time, objective measure of the force that the catheter applies to a patient's heart wall during an ablation procedure.
Cardiac Rhythm news for specialists

SMART-AF trial shows AF ablation with contact force sensing catheter is safe and effective

Results from the SMART-AF trial, recently published in the Journal of the American College of Cardiology, have shown that the ThermoCool SmartTouch contact force-sensing catheter is safe and effective for the treatment of drug-refractory symptomatic paroxysmal atrial fibrillation.
Cardiac Rhythm news for specialists

Study finds nMARQ ablation catheter fast and effective for the treatment of paroxysmal atrial...

A recent feasibility study has found irrigated multi-electrode radiofrequency ablation of atrial fibrillation using the novel 10-pole circular, open-irrigated mapping and ablation catheter nMARQ device (Biosense Webster) to be fast and effective.

St Jude Medical announces CE mark approval and first use of FlexAbility ablation catheter

The device has been designed to reduce complications associated with ablation procedures through its ability to bend and conform to the cardiac anatomy, decreasing the amount of pressure distributed to a patient's heart wall while simultaneously increasing the stability of therapy delivery.

Advanced Cardiac Therapeutics announces new financing for TempaSure cardiac ablation catheter for treatment of...

The financing, which was led by New Enterprise Associates and supported by existing investor, NBGI Ventures, will enable the company to continue to advance its next generation TempaSure ablation catheters and related clinical development programme.
Cardiac Rhythm news for specialists

Therapy Cool Flex Ablation Catheter and Cardiac Ablation Generator get FDA approval

The FDA has approved St Jude Medical's Therapy Cool Flex Ablation Catheter and Cardiac Ablation Generator for the treatment of atrial flutter.
Cardiac Rhythm news for specialists

FDA approval for IntellaTip MiFi XP ablation catheter and 510(k) clearance of Zurpaz 8.5F...

Boston Scientific Corporation has announced it has received US Food and Drug Administration (FDA) approval of its IntellaTip MiFi XP catheter and 510(k) clearance of its Zurpaz 8.5F steerable sheath. The IntellaTip is indicated for ablation of atrial flutter.
Cardiac Rhythm news for specialists

FDA approval and first use of MediGuide enabled ablation catheters announced

St Jude Medical announced on 15 August that the US Food and Drug Administration (FDA) has approved its MediGuide enabled ablation catheters. The catheter can be tracked using 3D visualisation on previously recorded fluoroscopic images in real time.
Cardiac Rhythm news for specialists

Boston Scientific completes first-in-human clinical trial of the IntellaTip MiFi XP Ablation Catheter for...

A company release states that this new line of ablation catheters is designed to provide physicians with high resolution, precise, multidimensional information through sophisticated micro-sensors at the tip of the catheter.
Cardiac Rhythm news for specialists

First US case performed with Endosense’s Tacticath Quartz contact-force sensing ablation catheter

The first US case was performed on 31 January 2013 as part of an amended protocol of the company's TOCCASTAR investigational device exemption clinical study of the TactiCath called the TOCCASTAR Supplemental Clinical Study.
Cardiac Rhythm news for specialists

First patient treated in trial to evaluate the safety and performance of the Blazer...

The ZERO AF study will include up to 33 sites in the USA, Europe and Asia-Pacific, and the results will be used to support a FDA submission for a paroxysmal AF indication.
Cardiac Rhythm news for specialists

Gold-tip ablation catheters create lesions 33% faster than platinum-iridium-tip catheters

Results from the GOLDEN TIME study have shown that gold-tip radiofrequency ablation catheters enable faster, more efficient ablation procedures than platinum-iridium-tip catheters.
Cardiac Rhythm news for specialists

TactiCath Quartz Force-Sensing Ablation Catheter gets CE mark approval

Endosense and Biotronik have announced that Endosense's TactiCath Quartz force-sensing ablation catheter has been CE mark approved in Europe.
Cardiac Rhythm news for specialists

“The future of AF ablation catheter technologies”: A new report reveals the potential of...

Design and technology consultancy Cambridge Design Partnership has announced that it has completed a research project to identify the future of medical technology to treat atrial fibrillation.
Cardiac Rhythm news for specialists

First atrial flutter patient treated with novel MRI ablation catheter

The development of this novel catheter, specially designed to be used with magnetic resonance imaging, could represent a significant new opportunity for improved therapy of complex cardiac arrhythmias.
Cardiac Rhythm news for specialists

Mount Sinai performs first US cardiac ablation using contact force-sensing catheter to treat atrial...

The first catheter ablation procedure was performed at the end of February by Vivek Y. Reddy, director of the Cardiac Arrhythmia Service at Mount Sinai Heart and colleagues.
Cardiac Rhythm news for specialists

First clinical ablation cases in the EU using the Thermocool Smarttouch contact force sensing...

The CE-marked Thermocool Smarttouch catheter provides an important new parameter for the mapping and ablation of complex cardiac arrhythmias, such as atrial fibrillation.
Cardiac Rhythm news for specialists

TOCCASTAR IDE study of TactiCath force-sensing ablation catheter (Endosense) is launched

TOCCASTAR will explore a new catheter ablation treatment option for patients who have symptomatic paroxysmal atrial fibrillation and who are resistant or intolerant to at least one Class I-IV anti-arrhythmic drug.
Cardiac Rhythm news for specialists

New Lynx robotic irrigated ablation catheter is presented at Venice Arrhythmias

Hansen Medical showcased the small, flexible irrigated ablation catheter for the first time. CE mark is expected in the first half of 2010.
Cardiac Rhythm news for specialists

CardioFocus receives CE mark for AF ablation catheter

The device incorporates a micro-endoscope and light energy fibres to give physicians the capacity to see within the heart and visually direct the application of energy through a catheter.
Cardiac Rhythm news for specialists

Endosense receives CE mark for TactiCath force-sensing ablation catheter

Approval was granted based on select data submitted from the TOCCATA clinical study, which was performed by 17 experienced investigators at eight European centres.
Atrian

AtriAN initiates second trial of pulsed field ablation in cardiothoracic surgery patients with paroxysmal...

AtriAN Medical has announced that it has completed enrolment of a second study using its selective pulsed field ablation (PFA) technology for the treatment...

Biosense Webster launches Octaray mapping catheter

Biosense Webster has announced the release of the Octaray mapping catheter, developed for the mapping of cardiac arrhythmias including atrial fibrillation (AF). The catheter...

FDA approves clinical trial of SERF ablation for VT patients

Thermedical has announced that the US Food & Drug Administration (FDA) has approved an open-label, single-arm interventional clinical trial to evaluate the safety and...

First-in-man study yields promising results for saline-enhanced radio frequency VT ablation

A first-in-human multicentre trial using in-catheter, heated saline-enhanced radio frequency (SERF) ablation for patients with ventricular tachycardia (VT) has reported that the technique showed...

Stereotaxis submits CE mark application for MAGiC catheter

Stereotaxis has announced the CE mark submission for its MAGiC catheter, a robotically navigated magnetic interventional ablation catheter for minimally invasive cardiac ablation procedures. MAGiC...

HRS 2022: Registry data support role of cardioneural ablation to address vasovagal syncope

Findings of the US multicentre cardioneural ablation (CNA) registry were presented during a late-breaking clinical trial session at the Heart Rhythm Society’s 2022 annual...

New data underpin drive towards earlier AF ablation strategies

Historically, catheter ablation has been reserved for atrial fibrillation (AF) patients who have failed to respond to, or tolerate antiarrhythmic drug therapy, electrophysiologist Dhiraj...
ablation

Hot balloon ablation and cryoballoon ablation deemed effective for AF treatment 

Both cryoballoon ablation (CBA) and hot balloon ablation (HBA) are effective treatment options for atrial fibrillation (AF), however, patients treated with HBA are more...
Jose Osorio

Q-FFICIENCY trial shows promise for temperature-controlled ablation  

Use of temperature-controlled ablation for the treatment of atrial fibrillation (AF) is effective and highly efficient, according to Jose Osorio—the director of electrophysiology at...

Study shares success of complete PVI using only pulsed field ablation 

A recent study has demonstrated 100% pulmonary vein isolation (PVI) using only pulsed field ablation (PFA), resulting in no PFA-related serious adverse events. This...

Contact force-guided ablation for typical atrial flutter does not reduce recurrent atrial arrhythmia

Contact-force (CF)-guided ablation to treat typical atrial flutter does not reduce recurrent atrial arrhythmia at 12 months follow-up, in comparison to ablation blinded for...

First patients treated using Adagio Medical’s pulsed field cryoablation system

Adagio Medical has announced first-in-human cases of pulsed field cryoablation (PFCA) for the treatment of atrial fibrillation (AF). The cases were performed at Medicover Hospital,...

Patients undergoing robotic ablation found to have reduced incidence of silent cerebral embolism

Stereotaxis has announced the publication of the results of a prospective, multicentre study comparing the incidence of silent cerebral embolism (SCE) in atrial fibrillation...

Pulsed field ablation poised to revolutionise the treatment of atrial fibrillation

The advent of pulsed field ablation (PFA) will revolutionise the treatment of atrial fibrillation (AF), Tom de Potter (Aalst, Belgium) tells Cardiac Rhythm News,...

Study shows safety and efficacy of robotic-guided ablation to treat paediatric arrhythmias

Stereotaxis has announced publication of a study in the International Journal of Cardiology: Heart & Vascular demonstrating superior safety and efficacy of Stereotaxis’ robotic...

Targeting atrial fibrosis in AF patients with low levels of disease “may help improve...

Image-guided fibrosis ablation in addition to pulmonary vein isolation (PVI) does not improve ablation success rates compared to PVI alone in patients with persistent...

Adagio’s ultra-low temperature cryoablation system in first-in-human use

Adagio Medical has announced successful first-in-human use of ultra-low temperature cryoablation (ULTC) for the treatment of monomorphic ventricular tachycardia (VT). The two-hour mapping and ablation...

RAFT-AF fails to show benefit of AF ablation in heart failure patients

Among patients with both heart failure and atrial fibrillation (AF), treatment strategies focused on rhythm control, using catheter ablation, and those focused on rate...

Single-shot pulsed-field ablation yields “excellent” PVI durability

Pulmonary vein isolation (PVI) with a “single-shot” pulsed-field ablation (PFA) catheter results in excellent PVI durability and acceptable safety with a low one-year rate...

First patients treated in ADVENT trial of pulsed field ablation system

FARAPULSE has announced that the first patients have been treated in the ADVENT trial, a US Food and Drug Administration (FDA) Investigational Device Exemption...

AF Symposium 2021: Experts debate early ablation strategy in AF

The merits of catheter ablation as a first-line treatment for atrial fibrillation (AF) were considered during the second day of AF Symposium 2021 (29–31...

AF Symposium 2021: Studies explore lattice-tip catheter strategies for AF

Findings of two studies investigating the use of a lattice-tip catheter for the treatment of atrial fibrillation (AF) were presented during a late-breaking trial...

Medtronic receives FDA approval for DiamondTemp ablation system

Medtronic has received US Food and Drug Administration (FDA) approval for the DiamondTemp ablation (DTA) system which treats patients with recurrent, symptomatic paroxysmal atrial...
Kardium Globe PFA

Kardium secures financing to advance Globe mapping and ablation system

Kardium has raised US$115 million in a new financing round, which will be used to accelerate commercial growth of the Globe mapping and ablation...

PRECAF study looks at elimination of distal coronary sinus to left atrial connection for...

Elimination of distal coronary sinus (CS) to left atrial (LA) connections reduced atrial arrhythmia recurrences compared to standard pulmonary vein (PV) isolation and non-PV...
The HeartLight Excalibur Balloon used with the HeartLight X3 system

CardioFocus announces 10,000-patient milestone for HeartLight ablation system

CardioFocus has announced that more than 10,000 patients worldwide have been treated with the HeartLight endoscopic ablation system. The HeartLight system is a catheter ablation...

Acutus Medical launches the AcQBlate force sensing ablation system in Europe

Acutus Medical has announced the launch of the AcQBlate force sensing ablation system in Europe after securing CE mark for the company’s AcQBlate FORCE...
Medtronic's Arctic Front Advance cryoballoon

AHA 2020: Medtronic shares results of cryoablation studies

Medtronic has announced the presentation of results of three studies which it says demonstrate that cryoablation is superior to drug therapy for first-line treatment...

Holographic ablation guidance system gains US FDA clearance

SentiAR has received US Food and Drug Administration (FDA) 510(k) clearance for its CommandEP system, the first holographic guidance system to be used during...

First patients in Europe treated with Biosense Webster Varipulse catheter

Johnson & Johnson has announced that Biosense Webster has enrolled and treated the first patients in its inspIRE clinical study in Europe. The study...

Boston Scientific to invest in pulsed field ablation device developer

Boston Scientific has signed an investment agreement with an exclusive option to acquire Farapulse, a privately-held company developing a pulsed field ablation (PFA) system...

ESC 2020 Congress: STOP AF First finds cryoballoon ablation safer than drug treatment for...

Cryoballoon catheter ablation as a first line treatment for paroxysmal atrial fibrillation (AF) was found to be safer and more effective than anti arrhythmic...

Integrated cardiac ablation performed using remote telerobotic system

Stereotaxis and Acutus Medical have announced the first integrated cardiac ablation procedure using remote TeleRobotic support. Gery Tomassoni of Baptist Health, Lexington, USA treated...

Holographic display may improve physician accuracy during cardiac ablation

Details of the first-in-human use of an augmented reality holographic display to aid physician accuracy during cardiac ablation have been published in the Journal...

Lower rate of post-ablation arrhythmia recurrence found in patients with shorter AF episodes

Patients with atrial fibrillation (AF) episodes limited to less than 24 continuous hours had a significantly lower incidence of arrhythmia recurrence following AF ablation...

NuVera announces successful first-in-human use of NuVision ICE catheter

NuVera Medical has announced the initiation of the company's first-in-human clinical trial to evaluate the performance of its NuVision intracardiac echocardiography (ICE) catheter. The...
Kardium Globe PFA

Kardium receives CE mark for its Globe Mapping and Ablation System

Kardium has received CE mark approval for its Globe Mapping and Ablation System for the treatment of atrial fibrillation (AF). “This is an important milestone...

Adagio Medical receives CE mark for iCLAS ablation system

Adagio Medical has received CE mark approval for its ultra-low temperature intelligent Continuous Lesion Ablation System (iCLAS) for the endocardial treatment of paroxysmal (PAF)...

Same-day discharge “feasible for majority of AF ablation patients”

Same-day discharge after atrial fibrillation (AF) ablation is feasible for the majority of patients when a standardised protocol is used, findings of a multicentre cohort study, published in the Journal of the American...

AF Symposium 2020: Cryoablation pulmonary vein isolation is safe and effective for persistent atrial...

Hugh Calkins (Johns Hopkins Medical Institutions, Baltimore, USA) told delegates attending the AF Symposium 2020 (23–25 January, Washington, DC, USA) that cryoablation with the...
Vivek Reddy

AF Symposium 2020: Myocardial specificity of pulsed field ablation provides safety advantage for persistent...

At the AF Symposium 2020 (23–25 January, Washington, DC, USA), Vivek Y Reddy (Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, USA)...

Hypocapnia could aid ablation of cardiac arrhythmias

A technique that enables patients suffering from heart conditions to hold their breath safely for over five minutes could have potential as a treatment...
The HeartLight Excalibur Balloon used with the HeartLight X3 system

CardioFocus treats first patients with HeartLight endoscopic ablation system in France

CardioFocus has announced that the first patients in France have been treated in the University Public Hospital of Nancy with the HeartLight endoscopic ablation...

Almost one in 200 patients die early after AF ablation in a real-world analysis...

Early mortality following atrial fibrillation (AF) ablation affects nearly one in 200 patients, with the majority of deaths occurring during 30-day readmission, an analysis...
Abbott-mapping catheter

The Advisor HD Grid Mapping Catheter, Sensor Enabled, maps at high resolution and is...

Disclaimer: This advertorial is sponsored by Abbott The Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ (SE), is a unique mapping catheter that, when used with...

Boston Scientific initiates trial comparing left atrial appendage closure to direct oral anticoagulants for...

According to a press release, Boston Scientific has initiated the OPTION trial to compare safety and effectiveness of the next-generation Watchman FLX left atrial...

High power short duration ablation for atrial fibrillation: Safety and effectiveness

As part of a session on novel mapping and ablation technologies of atrial fibrillation (AF) at the recent AF Symposium in Boston, USA (24–26...

CABANA finds reduced AF and better quality of life after ablation but no reduction...

Catheter ablation for atrial fibrillation leads to a reduction in atrial fibrillation, better quality of life and lower hospitalisations than medical therapy, but does...

Late-breaking trial highlights positive safety and efficacy data for the LUMINIZE RF balloon catheter

Boston Scientific announced data from the AF-FICIENT I study during a late-breaking clinical trial session at the 2019 European Heart Rhythm Association annual congress...
New ESC guidelines on SVTs

First US clinical study to assess ablation for monomorphic ventricular ablation initiated

Abbott has announced the start of LESS-VT—the first US clinical trial to evaluate the safety and effectiveness of ablation treatment for patients with monomorphic...

Case report: Mapping a complex macroreentrant atrial arrhythmia in congenital heart disease after surgical...

This article has been sponsored by Abbott Case description A 31 year-old female with tricuspid atresia and normally related great vessels who underwent an atriopulmonary Fontan...

CABANA trial provides important new data on clinical and quality of life effects of...

Catheter ablation for atrial fibrillation (AF) produced no significant improvement in death, disabling stroke, serious bleeding, or cardiac arrest but did reduce death or...

Ultralow temperature ablation: Results from the Cryocure I and Cryocure II trials

The trials found that ultralow temperature cryoablation is feasible and shows excellent safety and efficacy. The clinical outcomes for flutter ablation show a 94%...

Real-time lesion formation and gap detection during ablation: DURABLE-I follow-up

One-year results from the Dielectric Unravveling of RAdiofrequency ABLation Effectiveness (DURABLE-I) clinical trial have shown that the KODEX (Navix International Limited) system help to...

Case report: Usefulness of high resolution mapping with mini-electrodes to select ablation site...

This article has been sponsored by Boston Scientific. Case description A 62-year-old woman, with recent sinus venosus atrial septal defect correction surgery, developed a persistent macroreentrant...

Sheath designed to reduce radiation exposure and improve ablation procedure efficiency launched

The CARTO VIZIGO Bi-directional Guiding Sheath is now available in the United States. This is the first commercially available steerable guiding sheath that can be...

DEEP-guided ablation may enable better treatment of ventricular tachycardia

Results from a multicentre study of catheter ablation guided by DEEP (decrement-evoke potential) mapping show that using DEEP mapping meant that ablation was successful...

Successful ablation for ventricular tachycardia associated with markedly reduced mortality in advanced heart failure...

    Wendy Tzou (University of Colorado School of Medicine, Denver, USA) and colleagues at the International Ventricular Tachycardia Ablation Center Collaborative group (IVTCC) published two...

First patient treated in SHINE study of multi-electrode radiofrequency balloon catheter

The first patient has been enrolled and treated in the SHINE clinical study in Europe. The multicentre study aims to evaluate balloon ablation catheter...
Natalia Trayanova envisions the future of cardiology and electrophysiology advancing through personalised medicine and computational simulations. Trayanova is the director of the Computational Cardiology Lab at Johns Hopkins University (Baltimore, USA), as well as the Murray B Sachs professor in the Department of Biomedical Engineering and the university’s Institute for Computational Medicine. In this commentary, she discusses her research and the potentials of combining clinical imaging with computational modelling to create a unique virtual heart–one for every patient

Imaging-based simulations for predicting sudden death and guiding ablation

Natalia Trayanova envisions the future of cardiology and electrophysiology advancing through personalised medicine and computational simulations. Trayanova is the director of the Computational Cardiology...

Less bleeding in ablation with interrupted dabigatran compared to uninterrupted warfarin 

The results of ABRIDGE-J, a Japanese multicentre randomised study on minimally interrupted dabigatran vs. uninterrupted warfarin for catheter ablation, were presented during a late-breaking...
imricor

Imricor announces completion of enrolment for MRI-guided ablations clinical study

Imricor Medical Systems announced today the completion of enrolment for the clinical study to evaluate Imricor’s Vision-MR Ablation Catheter for the treatment of atrial flutter...
Noninvasive radioablation

Noninvasive radioablation: Radiotherapy shows 99.9% VT burden reduction

A small study by Phillip S Cuculich (Washington University School of Medicine, St Louis, USA) et al has shown that  radiation therapy, commonly used...
imricor

Imricor announces new developments in MR compatible ablation products

Imricor is developing a magnetic resonance (MR) compatible injection catheter and has announced a joint development agreement with MiRTLE Medical to integrate MiRTLE’s MR...

Repeat ablation with contact force sensing “does not necessarily guarantee a successful outcome” in...

Preliminary results from the ABLATOR observational registry have shown similar success rates (around 58%) in first time ablation and repeat ablation for persistent atrial...

CardioFocus receives approval for HeartLight Endoscopic Ablation System in Japan

CardioFocus has announced that the Japanese Ministry of Health, Labour and Welfare has approved the HeartLight Endoscopic Ablation System for the treatment of paroxysmal atrial fibrillation...

Rate of early death after ventricular tachycardia ablation as high as 5%

Early post-procedural mortality occurred in 5% of cases of radiofrequency catheter ablation in patients with scar-related ventricular tachycardia (VT), with more than half of...
Cardiac Rhythm news for specialists

Biosense Webster launches Carto 3 system Carto Visitag module with Ablation Index

Biosense Webster has launched of the Carto Visitag module with Ablation Index, a new technology providing visual indication based on the integration of power,...

ACC 2017: Uninterrupted dabigatran performs better than warfarin in atrial fibrillation ablation

Results from the RE-CIRCUIT study have shown that uninterrupted dabigatran (Pradaxa, Boehringer Ingelheim), was associated with fewer bleeding complications than uninterrupted warfarin before, during...

ACC 2017: Anticoagulant treatment may be unnecessary for stroke prevention following ablation for atrial...

For patients with persistent atrial fibrillation or those who are at high risk for recurring atrial fibrillation, catheter ablation is recommended, followed most often...

AF ablation associated with phrenic nerve injury: Is this complication now in our rear...

Phrenic nerve injury is a well-established complication of all types of atrial fibrillation (AF) ablation and is most common with balloon-based approaches, writes Hugh...

US FDA approves Abbott’s FlexAbility Catheter, Sensor Enabled

The FlexAbility Ablation Catheter, Sensor Enabled is designed to improve the versatility and precision during cardiac ablation procedures to treat atrial flutter. The Sensor Enabled...

Multielectrode mapping may be more effective than point-by-point mapping for VT substrate ablation

Results from the first randomised study comparing multielectrode mapping vs. conventional point-by-point mapping for ventricular tachycardia (VT) substrate ablation procedures have shown that a...

STS recommends surgical ablation as an “effective” treatment for atrial fibrillation

The Society of Thoracic Surgeons (STS) has issued new clinical guidelines that include major recommendations for the use of surgical ablation when treating atrial...

In search of innovative technologies for ventricular tachycardia ablation with cryoenergy

A proof-of-concept study has demonstrated that a new cryoablation system, which achieves “much cooler” temperatures than previous cryoablation technologies, is able to create large,...

OSYPKA AG launches HAT500® RF ablation system in Europe

OSYPKA AG has announced the launch of the HAT500® radiofrequency (RF) ablation system in Europe. The device received CE mark in October 2016. OSYPKA AG,...

Cryoballoon ablation demonstrates lower healthcare system costs compared to radiofrequency ablation

Analyses from the FIRE AND ICE trial has shown lower costs with cryoballoon catheter ablation compared to radiofrequency ablation—related to trial period—as a result...
Cardiac Rhythm news for specialists

ESC 2016 Clinical Practice Guidelines describe benefits of cryoballoon ablation and long-term cardiac monitoring

Cryoballoon ablation for patients with diagnosed atrial fibrillation, and long-term cardiac monitoring for survivors of stroke who do not have an established diagnosis of atrial...

King’s College London joins with Cambridge Design Partnership to further develop a new steerable...

Cambridge Design Partnership recently announced it is working with Kings College London to further develop a new steerable catheter designed to treat complex cardiac...

Biosense Webster announces US launch of ThermoCool SmartTouch SF catheter

Biosense Webster has announced the US launch of the ThermoCool SmartTouch SF catheter. According to a company release, the catheter pairs contact force technology...

Relevance of imaging for ventricular tachycardia ablation

Cardiac imaging has emerged as an integral part of mapping and ablation in a variety of complex arrhythmias. Advances in imaging techniques, especially the...

Texas Children’s Hospital is the first paediatric institution in USA to offer magnetic navigation...

Stereotaxis has announced that Texas Children’s Hospital in Houston, USA, has installed the its Niobe ES system, which according to the company, is the only...

Ablation of frequent premature ventricular complex allows safe withholding of ICD implant

Patients with frequent premature ventricular complex and primary prevention implantable cardioverter defibrillator (ICD) indication who undergo ablation may be able to avoid ICD implant,...

Catheter Robotics acquires VIVO product line; changes name to Catheter Precision

Catheter Robotics has completed the acquisition of a new product line to be named VIVO. The line is a computerised three-dimensional cardiac-mapping system showing...

Fewer repeat ablations and hospitalisations with cryoballoon demonstrated in FIRE AND ICE

New data from the FIRE AND ICE clinical trial have shown significantly fewer repeat ablations and lower hospitalisation rates for patients with paroxysmal atrial...

Cryoballoon ablation for AF may be economically favourable compared with focal radiofrequency ablation

A subsequent study of the Value PVI (pulmonary vein isolation) study report several economic benefits, including reduced staff overtime and more time remaining for...

Ventricular tachycardia ablation in Chagas disease

Guilherme Fenelon (Sao Paulo, Brazil) overviews the role of ablation of ventricular tachycardia in Chagas disease. He says: catheter ablation in Chagas disease remains...

First randomised trial shows “poor outcomes” with rotor ablation

OASIS, the first randomised, controlled, multicentre clinical trial to compare rotor-only ablation with two other ablation strategies in non-paroxysmal atrial fibrillation patients found “poor...

Ablation should be “preferred approach” in drug-resistant ventricular tachycardia

A multicentre, randomised controlled trial has shown that catheter ablation is superior to intensified antiarrhythmic drug therapy in reducing death, appropriate implantable cardioverter defibrillator...

FDA approves Boston Scientific navigation-enabled IntellaNav catheters

Boston Scientific has received US Food and Drug Administration (FDA) approval for two catheters that can be used with the company's Rhythmia mapping system.

Fluoroscopy times and radiation dose reduced in atrial fibrillation ablation with contact force-sensing technology

A real-world study has found that the SmartTouch (Biosense Webster) contact force-sensing catheter coupled with an Advanced Catheter Location feature during atrial fibrillation (AF) ablation reduced fluoroscopy times by 77%, radiation dose by 71% and procedural time by 19%.

Boston Scientific receives FDA approval for Blazer open-irrigated catheter

The approval of the Blazer OI catheter marks the first time Boston Scientific will offer an open-irrigated catheter to the US market.

How innovation can unleash tremendous growth in the $3.4 billion AF ablation market

Shlomo Ben-Haim (London, UK), a professor of medicine and serial entrepreneur in the medical device industry, examines the drivers of expansion of the atrial...

Hybrid and surgical atrial fibrillation ablation: Opportunity, threat or both?

Despite major advances in techniques and technology over the past 15 years, the clinical outcomes for catheter ablation in non-paroxysmal atrial fibrillation patients remain...

LuxCath technology demonstrates promising results during first-in-man cardiac ablation procedures

The LuxCath optical tissue interrogation technology was used in eleven patients suffering from arrhythmias such as atrial flutter, AV nodal re-entrant tachycardia, and atrial fibrillation.

Greater long-term success rates for Stereotaxis’ Niobe system compared to manual catheter

The results of an independent, multicentre study, which looked at the procedural benefits and outcomes of patients undergoing radio frequency ablation therapy for ventricular tachycardia, were published at the AHA.

Role of rotors in mapping and ablation of ventricular fibrillation

In recently published studies, modulation of rotors by ablation seems to be effective in termination of atrial fibrillation. Now, researchers are exploring the role of rotors in ventricular fibrillation. Siva K Mulpuru (Mayo Clinic, Rochester, USA), discusses the latest research in this field.
Cardiac Rhythm news for specialists

Westmead Hospital provides data supporting ablation effectiveness of Stereotaxis magnetic navigation

Stereotaxis and Westmead Hospital in Australia have announced findings of a study comparing the stability of a Niobe remote magnetic navigation system catheter group and a manually controlled catheter group in a validated cardiac wall motion simulator.
Cardiac Rhythm news for specialists

LuxCath LLC awarded US patent for real-time lesion visualisation technology for AF ablation

The LuxCath LLC system determines electrode-tissue contact as well as monitors lesion progression during ablation and provides real-time lesion visualisation without pressure sensors or ultrasound.

Advanced technologies to improve efficacy and safety of AF ablation

Technologies to image lesion creation in real time are required to improve the efficacy as well as the safety of atrial fibrillation (AF) ablation....
dabigatran

First patient enrolled in dabigatran study comparing anticoagulation strategies during atrial fibrillation ablation

The study assesses the safety and efficacy of uninterrupted anticoagulation with dabigatran etexilate (Pradaxa) during ablation procedures compared to warfarin. Results from the study are expected during 2016.

St. Jude Medical begins study of ablation procedures to treat ventricular tachycardia

The FlexAbility ablation catheter will be used to assess benefits of catheter ablation as an adjunctive therapy for patients at risk for life-threatening arrhythmias.

Medtronic initiates European trial to evaluate cryoballoon ablation treatment for atrial fibrillation

Cryoablation creates lesions by freezing tissue in the heart's upper chambers, traditionally around the pulmonary veins, to block the electrical signals that trigger erratic heart rhythms.

Non-invasive mapping prior to ablation may be an effective strategy for persistent atrial fibrillation

Preliminary data from the AFACART study have shown encouraging results when treating persistent atrial fibrillation with non-invasive mapping followed by pulmonary vein isolation and/or linear lesions.

AtriCure completes enrolment in post approval study for the Synergy Ablation System

AtriCure has announced that enrolment in the ABLATE post approval study (PAS) of its Synergy Ablation System is complete. As 3 October 2014, the ABLATE PAS enrolled 365 patients at 40 hospitals across the United States.

John Muir Health’s Concord medical centre one of 20 hospitals in USA to use...

John Muir Health's Concord medical centre is one of just 20 hospitals in the USA to begin treating patients who suffer from atrial fibrillation with a new procedure that features the FDA-cleared FIRMap catheter.
Cardiac Rhythm news for specialists

Sensei X robotic catheter system to be featured at Cardiostim

The Sensei X2 features faster image processing and a slimmer design with the stability and reachability of its predecessor. The improved processing and imaging capabilities of the Sensei X2 will also be available to users of the current Sensei X upon release.

Cryoballoon faster and more effective than conventional radiofrequency ablation for paroxysmal AF

A randomised controlled trial comparing three methods of pulmonary vein isolation for paroxysmal atrial fibrillation has revealed that procedures were faster and more effective with Medtronic's Arctic Front cryoballoon than wide encirclement using conventional point-by-point radiofrequency ablation. Procedures using the cryoballoon also resulted in a higher single procedure success rate.

Substrate based ablation superior than conventional ablation of stable clinical ventricular tachycardia

For stable clinical ventricular tachycardias, a substrate based ablation approach is more effective than conventional ablation preventing recurrences from any ventricular tachycardias in patients with ischaemic cardiomyopathy, according to results of the VISTA study, which is the first randomised trial performed in this area.

FDA approves Thermocool SmartTouch catheter

The first catheter ablation therapy in the US to feature direct contact force technology for treatment of atrial fibrillation, has been approved by the US Food and Drug Administration.
Cardiac Rhythm news for specialists

Apama Medical announces claim coverage in China for electrode-based ablation balloon for the treatment...

Apama Medical announced receipt of a Chinese notice of allowance for claims covering their low profile electrode assembly that enables the attachment of flexible electrodes to an ablation balloon for energy delivery and monitoring.

New combined mapping and ablation system for atrial fibrillation treatment undergoes testing

Hans Kottkamp, Zurich, Switzerland, presented a new device strategy that combines diagnostic and treatment capabilities for atrial fibrillation in one system, at the AF Symposium in Orlando USA (9-11 January 2014). He spoke to Cardiac Rhythm News about the combined system.

Ablation of persistent atrial fibrillation, are we there yet?

Mark Earley (London, UK) argues that despite the breathtaking progress of interventional electrophysiology in the last 10 years, ablation of persistent atrial fibrillation remains an unconquered summit.
Cardiac Rhythm news for specialists

HeartLight endoscopic ablation system can now be used in Spain

CardioFocus has announced that its HeartLight endoscopic ablation system is now available in Spain and Hospital Universitari i Politecnic La Fe in Valencia was the first in the country to use the technology.
Cardiac Rhythm news for specialists

Radiation exposure in supraventricular tachycardia ablation reduced with minimally fluoroscopic mapping system

Radiofrequency ablation of supraventricular tachycardia guided by the non-fluoroscopic Ensite NavX mapping system (St Jude Medical) has shown lower levels of ionising radiation exposure for the patient and for the operator compared with conventional catheter ablation, according to preliminary results from the NO-PARTY Italian trial.
Cardiac Rhythm news for specialists

Delayed enhancement-MRI detected atrial fibrosis could predict successful ablation in atrial fibrillation

Atrial fibrosis detected using delayed enhancement magnetic resonance imaging (DE-MRI) seems to be an independent predictor of procedural outcome in patients undergoing ablation of atrial fibrillation, according to results of the DECAAF (Delayed enhancement-MRI determinant of successful catheter ablation of atrial fibrillation) study
Cardiac Rhythm news for specialists

FDA clears Vdrive Robotic Navigation System with V-Sono Intracardiac Echocardiography catheter manipulator

The Vdrive with V-Sono system (Stereotaxis) is indicated for the remote control of compatible intracardiac echocardiography or ultrasound catheters inserted into the right atrium for cardiac ablation procedures.

The impact of radiofrequency ablation for atrial fibrillation on the gastrointestinal system

There have been a number of studies conducted to assess the efficacy and adverse effects of radiofrequency ablation of atrial fibrillation, but very little data is available on the effect of radiofrequency ablation on the upper gastrointestinal system. Dhanunjaya Lakkireddy, Kansas City, USA, reviews this subject based on the results of a new systematic approach the AF GUT study.
Cardiac Rhythm news for specialists

Ablation superior to medical therapy for patients with persistent atrial fibrillation

According to results from the SARA study, presented at a late-breaking trial session of the European Heart Rhythm Association (EHRA) Europace meeting (23-26 June, Athens, Greece), catheter ablation therapy has been shown to be superior to medical therapy for maintenance of sinus rhythm in patients with persistent atrial fibrillation.
Cardiac Rhythm news for specialists

Promising mid-term results from thoracoscopic ablation of persistent atrial fibrillation

At three-year follow-up, 80% of patients with persistent atrial fibrillation showed freedom from atrial fibrillation and were free from anti-arrhythmic drugs after thoracoscopic ablation with the Bipolar RF Ablation System (AtriCure).
Cardiac Rhythm news for specialists

FDA conditionally approves new study design for the Artisan family of control catheters with...

The US Food and Drug Administration (FDA) has given conditional approval to Hansen Medical to change the company's study design of its ARTISAN-AF trial.
Cardiac Rhythm news for specialists

Targeted ablation without pulmonary vein isolation shows 82% single procedure success rate in paroxysmal...

A late breaking trial presented at Heart Rhythm 2013 (8-11 May, Denver, USA) has demonstrated that targeted ablation of stable rotors and focal sources can eliminate paroxysmal atrial fibrillation without the need to isolate the pulmonary veins.
Cardiac Rhythm news for specialists

Hansen Medical to highlight Sensei Robotic Catheter System and new Artisan Extend Control Catheter...

On 29 April, Hansen Medical announced that it will showcase its Sensei X Robotic Catheter System with the new Artisan Extend Catheter at the Heart Rhythm Society's (HRS) 34th Annual Scientific Sessions (8-11 May, Denver, USA).
Cardiac Rhythm news for specialists

Endosense closes an additional US$4.3 million to finance ablation technology

The added finances will further support Endosense's programme to get access to the US market with its TactiCath Quartz contact-force sensing ablation catheter and to reinforce sales in Europe.
Cardiac Rhythm news for specialists

HeartLight Endoscopic Ablation System to be highlighted at Frankfurt Atrial Fibrillation Academy 2013

The Annual Frankfurt Atrial Fibrillation Academy Symposium will highlight the latest innovations and research in atrial fibrillation therapy.

Newer approaches in ablation for ventricular fibrillation

"Ventricular fibrillation was generally viewed as a non-ablatable rhythm disturbance. However, several advances over the last decade have enabled electrophysiologists to successfully address this arrhythmia with ablation techniques," writes Samuel J Asirvatham, Mayo Clinic, Rochester, USA.
Cardiac Rhythm news for specialists

Faster lower pacing rate after atrioventricular node ablation may help to decrease sudden death...

Faster lower pacing rate immediately after atrioventricular node ablation with a gradual decrease helps to improve clinical outcome and may reduce the risk of sudden death in patients with atrial fibrillation, Ru-Xing Wang and other reported in Heart Rhythm ahead of print.
Cardiac Rhythm news for specialists

St Jude Medical announces CE mark approval of ViewFlex Xtra ICE catheter

The new catheter provides real-time, high-resolution ultrasound images of blood flow and cardiac anatomy when paired with the ViewMate Z Intracardiac Ultrasound Console.
Cardiac Rhythm news for specialists

Minimally invasive hybrid ablation is safe and effective for treatment for atrial fibrillation patients

One year after treatment completion, 80% of patients in normal sinus rhythm without administration of drugs, study says.
Cardiac Rhythm news for specialists

Early data for over-the-wire mesh ablation system is “encouraging”

At Europe AF (18-19 November, London, UK), Dirk Mueller, Bad Bevensen, Germany said that the initial results of the GENESIS study validated the usability of the Over-the-Wire Mesh Ablation System (OTW MAS, Encompass, Bard Electrophysiology) for paroxysmal atrial fibrillation.
Cardiac Rhythm news for specialists

HeartLight Ablation System receives unique classification code in Germany for the treatment of atrial...

Use of the new code allows the German Institute of Medical Documentation and Information to track the number of atrial fibrillation patients being treated with laser ablation guided by endovascular endoscopy and provides the initial step to receiving a specific diagnosis-related group code for the procedure.
Cardiac Rhythm news for specialists

HeartLight Endoscopic Ablation System now available in Australia

Monash Medical Centre in Melbourne is the first cardiology centre in the country to offer this catheter ablation treatment.
Cardiac Rhythm news for specialists

ViewFlex Xtra Intracardiac Echocardiography catheter gets FDA clearance

ViewFlex Xtra Intracardiac Echocardiography catheter (St Jude Medical) is used to treat arrhythmias with radiofrequency ablation and to close atrial septal defects with structural heart procedures.
Cardiac Rhythm news for specialists

Biosense Webster introduces the Thermocool SF NAV catheter with Curve Visualization technology in USA

The Thermocool SF NAV catheter is designed to reduce fluoroscopy exposure to physicians, lab staff and patients alike, enhance visualisation of the ablation catheters orientation and improve procedural efficiency.
Cardiac Rhythm news for specialists

HeartLight Endoscopic Ablation System now available in the Netherlands

Physicians at Isala Klinieken in Zwolle, Netherlands, were the first in the country to incorporate CardioFocus' visually guided ablation technology.
Cardiac Rhythm news for specialists

New study to investigate the role of early radiofrequency ablation in delaying progression of...

ATTEST, a prospective, multicentre, randomised, controlled study will compare pulmonary vein isolation (using Biosense Webster's ThermoCool catheters and the company's Carto 3 or Carto XP mapping systems) with drug therapy (rate or rhythm control) in patients with paroxysmal atrial fibrillation.
Cardiac Rhythm news for specialists

Two poster presentations at Boston AF highlight positive results of a multidisciplinary ablation procedure

At Boston AF, two poster presentations showed that a multidisciplinary procedure that uses both epicardial and endocardial ablation (convergent procedure) is associated with high single procedure efficacy in a patient population dominated by persistent atrial fibrillation.
Cardiac Rhythm news for specialists

New consensus document for atrial fibrillation ablation previewed at Boston AF

Hugh Calkins, Maryland, USA gave a sneak preview of the forthcoming 2012 document on catheter ablation for atrial fibrillation. At Boston AF he said, the new document is not just a "brief update" of the previous HRS/EHRA/ECAS document, which was published in 2007, but a "comprehensive, state-of-the-art review of the field of catheter and surgical ablation for atrial fibrillation."
Cardiac Rhythm news for specialists

Single atrial fibrillation ablation procedure achieves high pulmonary vein isolation rates, study shows

Researchers in Germany achieve 98% acute pulmonary vein isolation, with 77% of patients in sinus rhythm at approximately nine months follow-up.
Cardiac Rhythm news for specialists

FDA approves Thermocool SF catheter

The Thermocool SF irrigated ablation catheter (Biosense Webster) has been approved for treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation when used with Carto systems and type 1 atrial flutter for patients 18 years and older.
Cardiac Rhythm news for specialists

Revised ablation guidelines previewed at Boston AF

Preview of the revised HRS/EHRA/ECAS consensus document on catheter ablation for atrial fibrillation at Boston AF (12-14 January 2012, Boston, USA) reveals new recommendation to use the CHADS2-VASc score
Cardiac Rhythm news for specialists

Endosense launches TactiCath 75 force-sensing catheter, announces new results of EFFICAS I clinical study

The TactiCath 75 is an 8.5 F sheath compatible, state-of-the-art open irrigated, steerable radiofrequency ablation catheter that employs the same proprietary force-sensing technology as the original TactiCath but features a longer, 75 millimeter curved tip.
Cardiac Rhythm news for specialists

FDA approves AtriCure’s Synergy Ablation system for atrial fibrillation treatment

AtriCure's Synergy Ablation system has been approved for the treatment of patients with persistent and long-standing persistent atrial fibrillation during open-heart concomitant coronary artery bypass grafting and/or valve replacement or repair procedures.
Cardiac Rhythm news for specialists

Estech starts patient enrolment in HISTORIC-AF European ablation study

The HISTORIC-AF staged hybrid ablation study will enrol persistent and long-standing persistent atrial fibrillation (AF) patients at ten centres in Italy, Germany, the United Kingdom, France, and Poland.
Cardiac Rhythm news for specialists

Boston Scientific begins marketing remote catheter system in Europe through exclusive agreement with Catheter...

The CRI Amigo system, compatible with certain Boston Scientific and other commercially available catheters, lets physicians remotely maneuver diagnostic and ablation catheters designed to treat common cardiac arrhythmias during electrophysiology procedures.
Cardiac Rhythm news for specialists

Measuring both left atrial size and the amount of left atrial fibrosis may improve...

A study, published in Heart, indicates that the combined assessment of left atrial size and the amount of left atrial fibrosis may improve the identification of patients who have a high likelihood of successful ablation.
Cardiac Rhythm news for specialists

FDA advisory panel votes against Medtronic Phased RF Ablation System for atrial fibrillation

The majority of the panel does not believe there is reasonable assurance of the safety of Medtronic's ablation system, and that the clinical benefits of the technology do not outweigh the potential risks based on the TTOP-AF clinical trial data.
Cardiac Rhythm news for specialists

Ablation therapy in atrial fibrillation patients shows to be effective but risky

The TTOP-AF trial results showed a 90% reduction in atrial fibrillation or atrial flutter burden in 55.8% of ablation patients; however the results did not meet the pre"defined performance safety goal of 16%.
Cardiac Rhythm news for specialists

Remote magnetic navigation and ablation shows promise in patients with scar-related ventricular tachycardia

"The main advantage of the Niobe Remote Magnetic Navigation System (Stereotaxis), is the precise mapping and identification of the critical diseased portions of the heart that allows physicians to perform ablation in a more effective way," said Petr Neuzil, lead investigator of the STOP-VT study presented at the ESC Congress in Paris.
Cardiac Rhythm news for specialists

HeartLight endoscopic ablation system available in the UK

HeartLight EAS (CardioFocus) is used for the treatment of atrial fibrillation. It features an illuminating endoscope to provide physicians with direct visualisation within a beating heart, in real time and without radiation.
Cardiac Rhythm news for specialists

EPi-Sense epicardial ablation system gets CE mark

The EPi-Sense (nContact) features first-of-its kind epicardial sensing electrodes designed to allow both electrophysiologists and cardiothoracic surgeons to map and navigate the epicardium and locate areas for linear epicardial ablation.
Cardiac Rhythm news for specialists

Medtronic announces FDA clearance and first patient procedure with the Achieve mapping catheter

Achieve is an intra-cardiac electrophysiology diagnostic catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation (PAF). The first patient procedure in the United States using this catheter was performed by Robert Kowal, electrophysiologist at the Baylor Heart & Vascular Hospital in Dallas, USA.

New AF ablation technologies: useful tools or just expensive toys?

Fiorenzo Gaita, Università degli Studi di Torino, Turin, Italy, spoke to Cardiac Rhythm news about the real impact of fluoroscopy, intracardiac echocardiography and virtual 3D electro-anatomic mapping in atrial fibrillation ablation.
Cardiac Rhythm news for specialists

Blazer Open-Irrigated catheter gets CE mark approval

Boston Scientific's latest radiofrequency ablation catheter is designed to treat a variety of arrhythmias and integrates Total Tip Cooling design which is intended to consistently cool the entire tip electrode during radiofrequency energy delivery.
Cardiac Rhythm news for specialists

Advanced Cardiac Therapeutics initiates first-in-man CE mark trial to study new catheter system

The Tempasure system is the world's first radiofrequency cardiac ablation catheter to offer both saline irrigation and temperature-sensing technology for the treatment of atrial arrhythmias.
Cardiac Rhythm news for specialists

New stretchable device promises to make ablation simpler

The new tool has all necessary medical devices printed on a standard balloon catheter: a device for eliminating damaged tissue using heat, temperature and pressure sensors, a light-emitting diode (LED) and an electrocardiogram sensor.
Cardiac Rhythm news for specialists

St. Luke’s Episcopal Hospital is among the first in the USA to offer cryoablation...

J Alberto Lopez, a physician affiliated with Texas Heart Institute at St. Luke's Episcopal Hospital, is the first in Houston and among the first in the nation to treat patients with paroxysmal atrial fibrillation with cryoablation technology.
Cardiac Rhythm news for specialists

Achieve mapping catheter is launched in Europe

The Medtronic's mapping catheter is an intra-cardiac electrophysiology recording catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation.
Cardiac Rhythm news for specialists

The European cardiac rhythm management, electrophysiology and ablation market valued at over €2.8 billion...

These markets could reach over €4.4 billion by 2017, according to a report published by iData Research.
Cardiac Rhythm news for specialists

Endosense and Siemens Healthcare work together in development project to improve electrophysiology ablation procedures

The main goal of the shared development project is to achieve an improved visualisation of catheter-tip-to-tissue contact force within a three-dimensional anatomic heart model during catheter ablation procedures.
Cardiac Rhythm news for specialists

Repeat ablation procedures provide “acceptable” long-term relief for AF patients

Five-year follow-up results from a study of catheter ablation for atrial fibrillation shows long-term success increases when outcomes are measured after the last ablation procedure.
Cardiac Rhythm news for specialists

FDA approves cryoballoon ablation treatment for paroxysmal AF

The Arctic Front Cardiac CryoAblation Catheter system is the first and only Cryoballoon in the United States indicated for the treatment of drug refractory paroxysmal atrial fibrillation.

Worldwide survey shows ablation works without drugs in most cases

Riccardo Cappato, Centre of Clinical Arrhythmia and Electrophysiology, Policlinico San Donato, Milan, makes his case following the second global survey on catheter ablation.
Cardiac Rhythm news for specialists

NIH funds innovative electroactive polymer based steerable catheter for the treatment of AF

The US$2.2 million grant will support the design and commercialisation of SPS's revolutionary steerable cardiac mapping and ablation catheter technology.
Cardiac Rhythm news for specialists

STOP-AF shows cryoablation prevents atrial fibrillation better than drugs

Professor Douglas Packer presents the results of two clinical trials conducted using the cryoablation technique.
Cardiac Rhythm news for specialists

CABANA pilot shows ablation more effective in preventing AF recurrence

Professor Douglas Packer presents the results of the pilot study at the American College of Cardiology Scientific Sessions.
Cardiac Rhythm news for specialists

Endosense launches next generation TactiCath force-sensing catheter

The second generation product includes an elegantly enhanced catheter along with a feature-rich supporting system called the TactiSysTM.
Cardiac Rhythm news for specialists

Promising results for cryoablation presented at ACC congress

Safety and effectiveness trial evaluated the Medtronic Arctic Front Cardiac CryoAblation Catheter System for the treatment of paroxysmal atrial fibrillation.
Cardiac Rhythm news for specialists

New study uncovers gender disparity in ablation treatment and outcomes for AF

Study published in HeartRhythm Journal shows female patients undergo catheter ablation less often and experience more complications than males
Cardiac Rhythm news for specialists

More centres perform ablation for persistent and permanent AF

New observations from the Second Worldwide Survey on AF Ablation showed that more procedures are being offered every year.
Cardiac Rhythm news for specialists

Trials beginning this year will compare AF ablation devices

An overview of clinical trials on AF ablation devices seeking FDA approval was presented by Hugh Calkins, Johns Hopkins Hospital, Baltimore, USA, at the Boston AF Symposium.
Cardiac Rhythm news for specialists

Stereotaxis is notified of the FDA approval of an additional magnetic irrigated catheter

The FDA also approved all magnetic catheters for use with newly increased field strength for magnetic navigation.
Cardiac Rhythm news for specialists

Mount Sinai first in nation to ablate AF using new visually-guided balloon catheter

Physicians at The Mount Sinai Medical Center in New York became the first in the US to ablate atrial fibrillation using the "Endoscopic Ablation System" manufactured by CardioFocus.

Advances in ablation of long-standing persistent AF

Matthew Wright, Hopital Cardiologique du Haut-Levaque, Bordeaux-Pessac, France talks about techniques and developments in catheter ablation for persistent AF.
Cardiac Rhythm news for specialists

Angiography could avoid coronary lesions after ablation in youngsters with a posteroseptal pathway

Study assessed the incidence of coronary artery injury early after catheter ablation for supraventricular tachycardias in children.
Cardiac Rhythm news for specialists

Increasing use of ablation to treat atrial fibrillation

American report says number of catheter ablation procedures for treating atrial fibrillation will fuel revenues in the electrophysiology ablation catheter market over the next five years.

British investigators demonstrate safety of AF ablation in the elderly

Investigators from The Heart Hospital, University College London, have demonstrated that atrial fibrillation ablation in older patients can be achieved safely with similar complication risks.

Highlights from ISCAT 2014

Michel Haissaguerre and Etienne M Aliot, chairmen of the International Symposium on Catheter Ablation Techniques (ISCAT; 15-17 October 2014, Paris, France), discuss the highlights of this year's meeting with Cardiac Rhythm News.
Cardiac Rhythm news for specialists

2010 ESC guidelines on atrial fibrillation followed by seven European countries, PREFER in AF...

The guideline-recommended use of oral anticoagulation has increased compared to previous registries, as well as the use of antiarrhythmic drugs and catheter ablation procedures. Data have recently been published in Europace
Cardiac Rhythm news for specialists

FDA clears Rhythmia Mapping System

The Rhythmia Mapping System (Boston Scientific) is a next-generation 3D mapping and navigation solution for use in cardiac catheter ablations and other electrophysiology procedures to diagnose or treat cardiac arrhythmias.

Andreas Goette

Andreas Goette is the chair of the European Heart Rhythm Association (EHRA) Europace Scientific Programme Committee. He spoke to Cardiac Rhythm News about his research in molecular electrophysiology, a subject which was absent 15 years ago. He also gave his views on antiarrhytmic drugs and catheter ablation technology, and spoke about the highlights of EHRA Europace 2013.
Cardiac Rhythm news for specialists

Rhythmia Mapping System gets CE mark

The Rhythmia Mapping System (Boston Scientific) is a next-generation 3D mapping and navigation solution for use in cardiac catheter ablations and other electrophysiology procedures to treat cardiac arrhythmias including: atrial flutter, atrial fibrillation and ventricular tachycardia.
Cardiac Rhythm news for specialists

Boston Scientific to acquire Rhythmia Medical

Rhythmia Medical is a developer of next-generation mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter.
Cardiac Rhythm news for specialists

“Clear gap” between guidelines and clinical practice

Elena Arbelo, Barcelona, Spain, presented one-year results from the first European study of real-life epidemiology of catheter ablation for atrial fibrillation. At the ESC annual meeting, Arbelo said: "There is a clear gap between recommendations and actual clinical practice."
Cardiac Rhythm news for specialists

Catharina Hospital and Philips start social media initiative with heart patient

A catheter ablation treatment of a patient with a heart rhythm disorder could be followed via social media, before, during and after the procedure. The initiative is lead by Catharina Hospital in The Netherlands and Philips.

The impact of the STOP-VT study

Rainer Moosdorf, Germany, reviews the impact of the STOP VT trial. As reported in the 14th issue of Cardiac Rhythm News, this multicentre study showed that remote magnetic navigation may provide additional benefits to catheter ablation for the treatment of scar-related ventricular tachycardia.
Cardiac Rhythm news for specialists

Novel nitinol guidewire associated with high success rate for transseptal punctures

A novel nitinol guidewire (SafeSept, Pressure Products) may be an alternative to transoesophageal or intracardiac echocardiogram for transseptal puncture for left atrium catheter ablation, study shows.
Cardiac Rhythm news for specialists

Robotic vs. magnetic navigation

Drs Andrea Natale and Carlo Pappone debate the merits of magnetic (Stereotaxis) or robotic (Hansen Medical) navigation for catheter ablation of atrial fibrillation.

Two decades of development in AF treatment and education

This year marked the 20th edition of the Atrial Fibrillation Symposium (AFIB2022; 24–25 May, Copenhagen, Denmark) which, over its lifetime, has evolved to become...

IMPACT II trial expands to USA following FDA exemption approval

The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to Attune Medical to evaluate the company’s ensoETM in the...

Study looks at efficacy of AI-based EGM analysis tool

Volta Medical has announced that peer-reviewed results from the company’s Ev-AIFib proof of concept study with its VX1 decision support software has been published...
diagnosing obstructive sleep apnoea

AHA scientific statement offers insight into sleep-disordered breathing and its link to arrhythmia

A new scientific statement from the American Heart Association (AHA) provides guidance about sleep-disordered breathing and its association with the development of cardiac arrhythmia.  Published...

First patients enrolled in IMPACT II study

Attune Medical has announced that the first patients have been enrolled in the IMPACT II— Improving Oesophageal Protection During Catheter Ablation for Atrial Fibrillation—study,...
atrial fibrillation

AF Symposium 2022: Lower pulmonary vein to left atrium volume ratio predicts AF recurrence

Pulmonary vein-left atrial (PV/LA) volume ratio is a significantly better predictor power for atrial fibrillation (AF) recurrence than LA dimension in patients with normal...

First patient treated in SPHERE PerAF trial

Affera has announced that the first patient was treated in the recently approved SPHERE PerAF trial, a US Food and Drug Administration (FDA) Investigational...

HRS 2021: Early rhythm control benefits AF patients with heart failure

Rhythm control therapy offers a clinical benefit when initiated within one year of a diagnosis of atrial fibrillation (AF) in patients with signs or...

Affera’s SpherePVI gets first-in-human use

Affera has announced the first-in-human use of its circumferential pulmonary vein isolation (PVI) pulsed field ablation (PFA) catheter, SpherePVI. The work was conducted as part...

Research highlights AF risk factors for HCM patients

The authors of research published in JACC: Clinical Electrophysiology claim that their findings will help physicians to identify, treat and prevent atrial fibrillation (AF)...
The HeartLight Excalibur Balloon used with the HeartLight X3 system

CardioFocus receives Japanese approval for HeartLight X3

CardioFocus has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the company's HeartLight X3 System for marketing in Japan....

Abbott initiates trial focusing on twin AF and heart failure treatments

Abbott has announced a new trial focused on improving the treatment for people simultaneously battling both atrial fibrillation (AF) and heart failure. The TAP-CHF trial...

AtriCure’s EPi-Sense system approved by US FDA for treatment of long-standing persistent AF

AtriCure has announced US Food and Drug Administration (FDA) approval of the EPi-Sense system to treat patients diagnosed with long-standing persistent atrial fibrillation (AF). The...

Putting the patient at the centre of the AF treatment strategy

This article was sponsored by Biosense Webster Putting the patient at the centre of the discussion is vital to setting the right strategy for the...

Looking ahead to AFIB2021

Far from being the first event in the electrophysiology calendar now to make the switch to a digital-only format, the 2021 edition of the...

AF burden at six months predictive of hard clinical outcomes in heart failure

Atrial fibrillation (AF) burden at six months after catheter ablation is predictive of all-cause mortality and heart failure hospitalisation,  in AF patients with heart...

ESC Congress 2020: EAST-AFNET 4 finds early rhythm control improves AF outcomes

Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy, according to results of the EAST-AFNET 4 trial presented in a Hot...

Prompt diagnosis “vital” in effective AF management

Dhiraj Gupta, consultant cardiologist and electrophysiologist at Liverpool Heart and Chest Hospital, (Liverpool, UK) discusses the current burden of atrial fibrillation (AF) on healthcare...

€3.7m funding round completed for cardiac AI developer inHEART

inHEART, developer of a cloud-based medical image analysis solution for cardiac interventions on patients with arrhythmias, has closed a funding round of €3.7m led...

HRS 2020 Science: Packer assesses CABANA’s legacy

As part of this year’s HRS 2020 Science virtual event Douglas L Packer (Mayo Clinic, Rochester, USA) delivered the 2020 Eric N Prystowsky lecture...

CONVERGE IDE trial results presented at HRS 2020 Science

AtriCure has announced results from the CONVERGE IDE clinical trial, which showed an 18% difference in favour of the hybrid Convergent procedure as compared...

EHRA 2020 to feature late-breaking arrhythmia studies

Twenty late-breaking trials, including major clinical studies on the treatment of atrial fibrillation (AF) are among the research to be presented at the annual...

Kalyanam Shivkumar named as editor-in-chief of JACC: Clinical Electrophysiology

Kalyanam Shivkumar has been named the next editor-in-chief of the Journal of the American College of Cardiology (JACC): Clinical Electrophysiology. Shivkumar is a physician scientist...

AF Symposium 2020: Use-as-needed NOAC strategy is safe and effective for selected AF patients

  Speaking today at the AF Symposium (23–25 January, Washington, DC, USA), Francis Marchlinski (Hospital of the University of Pennsylvania, Philadelphia, USA) reported that selected...

CardioFocus appoints Burke T Barrett as chief executive

CardioFocus, has announced that the company’s board of directors has promoted Burke T Barrett to the position of chief executive officer (CEO), effective January...

Leading electrophysiologists identify four key studies that will shape arrhythmia treatment in 2020

Leading electrophysiologists have pinpointed four clinical studies due to report findings in 2020—AMULET IDE, aMAZE IDE, PULSED AF and CEASE AF—that they expect to...
Eric Prystowsky

Eric N Prystowsky

Eric N Prystowsky (director of the Cardiac Arrhythmia Service at St Vincent Hospital, Indianapolis, and a consulting professor of medicine at Duke University Medical...

AtriCure announces completion of enrolment for aMAZE clinical trial

  AtriCure has announced the successful completion of patient enrolment in the aMAZE clinical trial. In addition, the company announced that it has received approval...

Pedro Brugada

With his brothers Josep and Ramon, Pedro Brugada discovered the syndrome that bears their name. He reflects on his career highlights with Cardiac Rhythm...
STSF Tip Illus on Surface Biosense Webster WEB

Biosense Webster launches initiatives to tackle atrial fibrillation

Biosense Webster, a Division of Johnson & Johnson, has reaffirmed its commitment to tackling atrial fibrillation (AF) by launching two major initiatives to coincide...

Cardiac Rhythm News Issue 46 – October 2019

Highlights: ESC guidelines on supraventricular tachycardias underline the pivotal role of catheter ablation therapy Study suggests increased use of DOACs in AF leads to...

AtriCure agrees to buy LARIAT developer SentreHEART

AtriCure has entered into a definitive agreement to acquire SentreHEART, which developed the LARIAT device for left atrial appendage closure in patients with atrial...

AtriCure enters into definitive agreement to acquire SentreHeart

AtriCure has revealed that it has entered into a definitive agreement to acquire SentreHeart. Under the terms of the acquisition agreement, the transaction consideration...
SentreHeart

SentreHeart announces initial clinical use of the Lariat with EpiRail procedure for LAA exclusion

SentreHeart recently announced it has successfully completed nine first-in-human procedures utilising the Lariat with EpiRail at John Paul II hospital in Krakow, Poland. The...
The HeartLight Excalibur Balloon used with the HeartLight X3 system

HeartLight expands its availability to more than 100 hospitals globally

The HeartLight Endoscopic Ablation System is now offered at more than 100 hospitals worldwide. CardioFocus highlighted the expanded availability of its catheter ablation technology...

Randomised controlled trial finds that efficacy is not compromised by using a shorter cryoapplication...

In a late-breaking session at the European Heart Rhythm Association annual congress (EHRA; 17–19 March, Lisbon, Portugal), Jason Andrade of Vancouver, Canada presented the...
Cardiac Rhythm news for specialists

Eliminate AF shows low thromboembolic and bleeding events with edoxaban

Uninterrupted anticoagulation with edoxaban (Lixiana, Daiichi Sankyo) resulted in low rates of thromboembolic and bleeding events in patients with atrial fibrillation undergoing catheter ablation,...

Is CABANA a positive or negative trial?

Several treatment options are available for atrial fibrillation (AF), including pharmacological rate or rhythm control, and catheter or surgical ablation. However, consensus as to...

Results of the CIRCA-DOSE study presented at EHRA 2019

In a late-breaking session at the 2019 European Heart Rhythm Association annual congress (EHRA; 17–19 March, Lisbon, Portugal), Jason Guy Andrade of Vancouver, Canada...

Combining practical and scientific learning to meet educational needs at Europe’s largest atrial fibrillation...

Sabine Ernst and Mattias Duytschaever are both consultant cardiologists and scientific committee members of the practical and scientific faculty of the Atrial Fibrillation Symposium,...

Tim Betts

For Tim Betts, a career in medicine was a natural choice. After graduating he knew he wanted to be a cardiologist and, with a...

New data on the VASCADE MVP system for multi-vessel closure following electrophysiology procedures

Cardiva Medical, an innovator in the field of vascular closure, has announced that new data from the randomised AMBULATE study will be presented in...

Biosense Webster announces first patients enrolled in post-market approval study for its novel tag-index...

Johnson & Johnson have announced that Biosense Webster has received approval from the US Food and Drug Administration (FDA) for its VISITAG SURPOINT External...

CONVERGE IDE clinical trial completes enrolment

Atricure have announced that the enrolment of the full cohort of 153 patients in the CONVERGE IDE clinical trial has been completed. CONVERGE IDE is...
Heart imaging has been successfully used to predict the benefit or futility of catheter ablation. The investigators described their findings in the Journal of the American College of Cardiology: Cardiovascular Imaging.

Call for paradigm shift to CPR competency to save 50,000 additional lives each year...

The American Heart Association (Association) and Laerdal Medical (Laerdal) are furthering their decades-long alliance to deliver a new standard of resuscitation quality and patient...

How gender impacts pathophysiology treatment of cardiac arrhythmia

Differences between men and women mean that outcomes after cardiac events can differ between the sexes. Cecilia Linde writes in Cardiac Rhythm News about...

Autonomic modulation for refractory ventricular arrhythmias: Going beyond the heart

Patients with scar-related ventricular tachycardia (VT) do not often achieve a cure. Jason S Bradfield and Kalyanam Shivkumar write in Cardiac Rhythm News about...

REAFFIRM: An interim analysis

The interim results of the REAFFIRM (Randomised Evaluation of Atrial Fibrillation treatment with Focal Impulse and Rotor Modulation guided procedures) trial showed there was...

Luigi Di Biase

Luigi Di Biase is a prominent electrophysiologist, section head of Electrophysiology, director of Arrhythmia Services, and professor of Medicine (Cardiology) at the Albert Einstein...

Cardiac Rhythm News Issue 41 – May 2018 EU edition

Highlights: Apixaban is a safe alternative to warfarin during catheter ablation of atrial fibrillation and may have a positive effect on cognitive function Stroke...

Cardiac Rhythm News Issue 41 – May 2018 US edition

Highlights: Apixaban is a safe alternative to warfarin during catheter ablation of atrial fibrillation and may have a positive effect on cognitive function Stroke...

Study to evaluate novel high power, short duration modality for treatment of atrial fibrillation...

The first patient has been enrolled and treated in the QDOT AF study (Biosense Webster). The study will evaluate the delivery of high...

Nassir Marrouche

Nassir Marrouche is a prominent electrophysiologist, executive director of the Comprehensive Arrhythmia Research and Management (CARMA) Centre at the University of Utah in Salt...

Stroke prevention drugs may help reduce dementia risk for atrial fibrillation patients

Patients with atrial fibrillation could reduce the risk of dementia by taking stroke prevention medications, according to recommendations published online in EP Europace1, a...

Clinical trial data further demonstrate safety and effectiveness of RHYTHMIA mapping system

Data from the TRUE-HD study has been announced during a late-breaking clinical trial session at the annual congress of the European Heart Rhythm Association...
Heart imaging has been successfully used to predict the benefit or futility of catheter ablation. The investigators described their findings in the Journal of the American College of Cardiology: Cardiovascular Imaging.

Biomarker predicts success of atrial fibrillation treatment

Written by Hannah Woolley, Cardiac Rhythm News Editor Heart imaging has been successfully used to predict the benefit or futility of catheter ablation. The investigators...
Sana Al-Khatib

The top 10 takeaways from the 2017 AHA/ACC/HRS guidelines

In October 2017, the American Heart Association/American College of Cardiology/Heart Rhythm Society (AHA/ACC/HRS) released a guideline document on the management of patients with ventricular...
Europe AF 2017

Five surprising messages from this year’s Europe AF

1. The "ILL-CONCEIVED" pallas study may be relaunched John Camm "I want to say just a few quick words about dronedarone", John Camm (St George's University of...

New guidelines on ventricular arrhythmias and sudden cardiac death

The American College of Cardiology (ACC), along with the American Heart Association (AHA) and the Heart Rhythm Society (HRS) has published new guidelines for...

Real-time cardiac mapping technology cleared by FDA

Acutus Medical has announced that the US Food and Drug Administration (FDA) cleared the AcQMap high resolution imaging and mapping system as well as...

Cardiac Rhythm News Issue 38 – October 2017 EU edition

Highlights: - Catheter ablation lowers mortality in atrial fibrillation patients with heart failure - Thrombus formation on LAA occlusion devices strongly associated with higher risk of ischaemic...

Sabine Ernst

Sabine Ernst (lead electrophysiology research/consultant cardiologist, Royal Brompton and Harefield Hospital, London, UK and associate lead for Cardiac Imaging in the Biomedical Research Unit...

Cardiac Rhythm News Issue 38 – October 2017 US edition

Highlights: - Catheter ablation lowers mortality in atrial fibrillation patients with heart failure - Thrombus formation on LAA occlusion devices strongly associated with higher risk of ischaemic...

EMA issues positive opinion for updated dabigatran summary of characteristics

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for an update to...

RE-CIRCUIT data to be included in European summary of product characteristics of dabigatran

The committee for medicinal products for human use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for an update to...

ESC 2017: EHRA and Biotronik mark 10 years of collaboration with the EHRA White...

At the European Society of Cardiology (ESC) congress (26–30 August, Barcelona, Spain), the European Heart Rhythm Association (EHRA) released an analytical supplement to the...

Remote monitoring allows earlier diagnosis of asymptomatic arrhythmias in patients with implantable loop recorders

The first study to assess the clinical impact of remote monitoring with the Reveal LINQ implantable loop recorder (Medtronic) has demonstrated the benefits of...

Tenth edition of EHRA White Book of cardiac arrhythmia treatment data released

The tenth year of data on cardiac arrhythmia treatment is being launched at EHRA EUROPACE - CARDIOSTIM 2017. The edition marks the ten year anniversary...

HRS 2017: Could etripamil nasal spray be a “game-changer” for paroxysmal supraventricular tachycardia?

A phase 2 trial (NODE-1) of a nasal spray formulation of etripamil (Milestone Pharmaceuticals) shows it is safe and effective at terminating paroxysmal supraventricular...
Cardiac Rhythm news for specialists

First patient enrolled in Daiichi Sankyo’s ELIMINATE-AF edoxaban study

The first patient has been enrolled into Daiichi Sankyo’s ELIMINATE-AF study. The multinational, randomised phase 3b study will explore the safety and efficacy of...

AtriCure names US principal investigator for the CONVERGE IDE clinical trial

AtriCure has announced David B DeLurgio as the US principal investigator for the CONVERGE IDE clinical trial. DeLurgio is a cardiac electrophysiologist at Emory Healthcare in Atlanta, USA. He is...
Cardiac Rhythm news for specialists

Superior vena cava does not seem to contribute to long-standing persistent atrial fibrillation

The arrhythmogenicity of the superior vena cava has been rarely detected in patients with long-standing persistent atrial fibrillation, according to study from China recently...

Moderate, habitual alcohol intake associated with atrial fibrillation

People who binge drink often experience an irregular heartbeat or a heart “flutter,” sometimes referred to as “holiday heart syndrome.” However, people who drink...

Jeremy Ruskin

Jeremy Ruskin (Boston, USA), professor of medicine Harvard Medical School and director emeritus of the Cardiac Arrhythmia Service and Clinical Electrophysiology Laboratory at Mass...

ESC and EACTS launch first collaborative atrial fibrillation guidelines

The first European Society of Cardiology (ESC) Guidelines on Atrial Fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) have been...

EHRA releases White Book 2016 EP Europace Supplement

The European Heart Rhythm Association (EHRA) and the EP Europace journal have released the supplement to its ninth annual EHRA White Book, developed in...

The OASIS trial: A critical appraisal

Recent results of the first randomised trial—OASIS trial—to compare rotor-only ablation with two other ablation strategies in non-paroxysmal atrial fibrillation patients found poor outcomes...

Etienne Aliot

Etienne Aliot (Nancy, France) has always been fascinated by the work of surgeons. This fascination set him on his path through medical school. He...

Afibmatters.org now in Swedish and Portuguese

The European Heart Rhythm Association (EHRA) is launching the patient- and caregiver-oriented website afibmatters.org in Swedish and Portuguese. Afibmatters.org aims to contribute to improvements in...

Reduced radiation exposure associated with Stereotaxis’ Niobe system

Stereotaxis has announced the results of a retrospective study conducted at Paracelsus Medical University in Nuremberg, Germany, which showed significantly reduced radiation exposure for...

George Van Hare

George Van Hare (The Louis Larrick Ward professor of Pediatrics and director, Division of Pediatric Cardiology, Washington University School of Medicine, St Louis, USA), has worked towards advancing paediatric electrophysiology, as a recognised specialty, in the paediatric cardiology world and the electrophysiology world. He considers that working as a paediatric electrophysiologist is a "rewarding" experience, because it has allowed him to diagnose and cure at a very early stage. He talks to C

HeartLight System gets FDA approval for atrial fibrillation treatment

CardioFocus has announced that it has received premarket approval from the US Food and Drug Administration (FDA) for its HeartLight Endoscopic Ablation System for the treatment of patients with paroxysmal atrial fibrillation.
Cardiac Rhythm news for specialists

First patient enrolled in international CEASE atrial fibrillation study

The first patient has been enrolled in the CEASE (combined endoscopic epicardial and percutaneous) atrial fibrillation (AF) clinical study, according to a press release from AtriCure.

New study has “major physiopathological and clinical implications” for the management of Brugada syndrome

Josep Brugada (Barcelona, Spain), Carlo Pappone (Milan, Italy) and others report in Circulation: Arrhythmia and Electrophysiology that ablation of abnormal epicardial substrate in patients with Brugada syndrome can eliminate the phenotype expression of the syndrome.

US societies release updated training requirements for clinical electrophysiology

Due to the complex nature of clinical cardiac electrophysiology, an updated training statement released by the American College of Cardiology, the American Heart Association and the Heart Rhythm Society, is calling for increased training for practitioners.
Cardiac Rhythm news for specialists

CardioFocus’ HeartLight PMA for the treatment of atrial fibrillation filed and accepted for review...

The accepted PMA application includes safety and effectiveness data from the company's multicentre HeartLight pivotal clinical trial, a randomised, controlled study in which a total of 353 patients were treated at 19 US centres.

Electrical left atrial appendage isolation helps to improve freedom from long-standing persistent AF

A randomised, multicentre study has found improvement in the long-term freedom from long-standing persistent atrial fibrillation (AF) in patients who underwent an ablation plus empirical electrical left atrial appendage isolation strategy. No major complications were reported.

FDA approves trial to evaluate Lariat ligation of the left atrial appendage as a...

The randomised, controlled AMAZE trial, will evaluate the use of the Lariat device for the ligation of the left atrial appendage as an adjunctive treatment to ablation in patients with persistent or long-standing persistent atrial fibrillation.

Biosense Webster launches Carto 3 system Confidense module

The Confidense module's proprietary algorithm streamlines data collection, annotation and validation for the market-leading Carto system.

Botox reduces AF burden for up to a year after cardiac surgery

Botulinum toxin injected into epicardial fat pads during coronary artery bypass graft surgery reduced the incidence of postoperative atrial fibrillation compared with placebo, with substantial suppression persisting after one year, a pilot study has found.

Data shows advantages of Acutus Medical Dipole Density Heart Imaging and Mapping System in...

The data was presented at the Heart Rhythm Society's 36th Annual Scientific Sessions (13-16 May, Boston, USA) and shows the systems benefits compared with standard voltage-based mapping in patients with atrial flutter.

HeartLight US pivotal study meets primary efficacy and safety endpoints

The trial, which randomised CardioFocus' HeartLight one-to-one versus the Biosense Webster Thermocool catheter, met both primary efficacy and safety endpoints and demonstrated a low learning curve for physicians.

First-in-human study backs neuromodulation to treat paroxysmal atrial fibrillation

A first-in-human study shows low level transcutaneous electrical vagus nerve stimulation, a completely non-invasive approach, suppresses paroxysmal atrial fibrillation.
Cardiac Rhythm news for specialists

Atrial fibrillation recurrence lower with sleep apnoea treatment

The use of continuous positive airway pressure was associated with a significant reduction in the recurrence of atrial fibrillation in patients with obstructive sleep apnoea, according to a new analysis of data.

First patients enrolled in DEEP clinical study

The study is the first-of-its-kind in the USA exploring a minimally invasive epicardial surgical ablation approach combined with an endocardial catheter-based ablation approach for the treatment of persistent or long-standing persistent atrial fibrillation.

Hansen Medical announces expanded protocol for the ARTISAN-AF IDE study

The amended protocol now includes the use of the Thermocool SmartTouch catheter (BioSense Webster) and the EnSite Velocity Cardiac Mapping System (St Jude Medical) in combination with the Sensei Robotic System (Hansen Medical) for the treatment of paroxysmal atrial fibrillation.

Hung-Fat Tse

While Hung-Fat Tse's initial research interests focused on device therapy for cardiac arrhythmias, he has dedicated his career to the development of cardiovascular regenerative medicine.

Non-invasive identification of drivers in persistent AF

In paroxysmal atrial fibrillation, pulmonary vein isolation is successful while the results in persistent atrial fibrillation are less satisfactory because of ill-defined atrial substrate...
Cardiac Rhythm news for specialists

Abbott completes acquisition of Topera

Abbott has acquired all outstanding equity of Topera for US$250m upfront, plus potential future payments tied to performance milestones.
Cardiac Rhythm news for specialists

Biosense Webster launches programme to reinforce patient benefits of company’s contact force therapy

The Biosense Webster Advantage programme is an outcomes-based, risk-sharing program for US hospitals that reinforces the significant patient benefits demonstrated by the ThermoCool SmartTouch Catheter.

Biosense Webster and StopAfib.org work to raise awareness of AFIB

Biosense Webster has partnered with advocacy organisation StopAfib.org to encourage Americans to "Get SMART About Afib."

AtriCure receives FDA approval to start DEEP IDE study

The DEEP study will investigate a minimally invasive approach performed by cardiac surgeons and electrophysiologists to treat patients with persistent or long-standing persistent atrial fibrillation who have failed antiarrhythmic drug therapy.

Abbott to acquire Topera and Advanced Cardiac Therapeutics

Abbott enters the catheter-based electrophysiology market with the announcement of an agreement to purchase Topera and the securement of the rights to purchase Advanced Cardiac Therapeutics (ACT). Both companies develop electrophysiology technologies for the diagnosis and treatment of heart rhythm disorders.

Persistent atrial fibrillation treatment with robotic navigation and contact force sensing shows promising results

An international multicentre registry evaluating the role of remote robotic navigation and contact force sensing in persistent atrial fibrillation (AF) treatment has found that, at one year, a higher proportion of patients treated with this modality were free from AF recurrences with a single procedure as compared with both manual/contact force sensing and robotic/no contact force sensing procedures.

Massimo Santini

Massimo Santini performed the first fulguration of the atrioventricular node of resistant supraventricular tachycardia in Italy; he also implanted a pacemaker in the Italian president Carlo Azeglio Ciampi, 10 years ago. Santini speaks to Cardiac Rhythm News about his views on advances in antiarrhythmic drugs, genetics and cardiac arrhythmias, and ECG screening.

Is antiarrhythmic gene therapy the future of atrial fibrillation management?

Dierk Thomas (Heidelberg, Germany) writes on the results of preclinical research on antiarrhythmic gene therapy.
Cardiac Rhythm news for specialists

TOCCASTAR trial meets primary safety and efficacy endpoints at Heart Rhythm 2014

Results from the first prospective, randomised study of contact-force ablation technology for the treatment of paroxysmal atrial fibrillation met primary endpoints and supplement the growing body of evidence that supports the safety and effectiveness of contact-force ablation technology.
Cardiac Rhythm news for specialists

St Jude Medical presents comprehensive clinical evidence during Heart Rhythm 2014

Clinical evidence about the company's cardiac rhythm management and ablation technologies will be provided in 38 sessions, including three late-breaking clinical trial sessions.

Antiarrhythmic drug therapy increases hospitalisation risk for older patients with atrial fibrillation and coronary...

A single centre analysis of antiarrhythmic drug therapy in older patients with atrial fibrillation and coronary artery disease has found it is associated with increased rehospitalisation at one year, and recommends safer and more effective therapies for symptom control in this group.

Limitations of novel oral anticoagulants challenge their widespread use

Even though novel oral anticoagulants present an "amazing opportunity to improve stroke prevention in atrial fibrillation", according to Peter Kowey (Philadelphia, USA), there are still several limitations with regards to monitoring, discontinuation, lack of reversal agents and lack of long-term data that affect their widespread use.

CABANA trial update

Douglas Packer (Mayo Clinic, Rochester, USA) shares with Cardiac Rhythm News information on the design and rationale of the CABANA (Catheter ablation versus antiarrhythmic drug...

Anne Curtis

Anne Curtis is past president (2005-2006) of the Heart Rhythm Society. She has been involved in various clinical trials in electrophysiology including her most recent trial, BLOCK HF, and is currently a member of different editorial boards in the field. She spoke to Cardiac Rhythm News about her career achievements, memorable cases and the major challenges executing a trial.
Cardiac Rhythm news for specialists

Management of atrial fibrillation still suboptimal in Europe

Results of EORP-AF, a pilot registry on the management and treatment of atrial fibrillation in Europe, have shown that compliance with treatment guidelines for atrial fibrillation patients with the lowest and higher stroke risk scores remains suboptimal.

Does the anatomy of left atrial appendage correlate with the risk of stroke?

Luigi Di Biase writes for Cardiac Rhythm News on the results of a study that identified four different left atrial appendage morphologies and its relationship with the risk of stroke in atrial fibrillation patients. "These results could have a relevant impact on the oral anticoagulation management and occlusion device management of atrial fibrillation patients with an intermediate risk for stroke," writes Di Biase.
Cardiac Rhythm news for specialists

Boston Scientific completes acquisition of Bard Electrophysiology

On 1 November, Boston Scientific closed on its previously announced agreement to acquire Bard EP, the electrophysiology (EP) business of CR Bard.
Cardiac Rhythm news for specialists

HeartLight US pivotal trial completes enrolment

The randomised, controlled trial of the HeartLight Endoscopic Ablation System (Cardiofocus) completed enrolment of over 400 patients from 21 research sites across the United States.

Antonio Raviele

Antonio Raviele (Venice, Italy), cofounder of the VeniceArrhythmias congress, implanted the first intravenous defibrillator lead in Italy. He spoke to Cardiac Rhythm News about this experience, his current research, his projects dedicated to enhance awareness on cardiac arrhythmias and the highlights of VeniceArrhythmias 2013

Latin American health policies adversely affect treatment of cardiac arrhythmias in the continent

Public health expenditure in Latin America is directed mainly to tackle diseases and social problems that kill the young population but not to treat cardiac diseases (including arrhythmias), which mainly affect older people, writes Diego Vanegas, Bogota, Colombia
Cardiac Rhythm news for specialists

Chinese electrophysiology market to grow approximately 20% in 2013

According to research by the Millennium Research Group, the Chinese electrophysiology market will grow approximately 20% in 2013, based on the largest available sampling of ablation procedures.
Cardiac Rhythm news for specialists

St Jude Medical acquires Endosense

St Jude Medical has announced the acquisition of Endosense. The acquisition adds to the company's electrophysiology portfolio. St Jude Medical has made an initial payment of approximately 159 million Swiss Francs (US$170 million) and acquired 100% of the outstanding equity of Endosense.
Cardiac Rhythm news for specialists

ESC and AEPC release consensus statement on paediatric arrhythmias

The consensus on paediatric arrhythmias is the first European statement concerning the diagnosis and management of paediatric arrhythmias. It is also the first joint document between European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) and the Association for European Paediatric and Congenital Cardiology AEPC.
Cardiac Rhythm news for specialists

Complete pulmonary vein isolation more effective in atrial fibrillation treatment

Complete linear lesions when using catether ablation to isolate pulmonary veins have been shown to be more effective than incomplete lesions in preventing recurrence of atrial fibrillation, according to results from the GAP-AF study presented at a late-breaking trial session of the European Heart Rhythm Association (EHRA) Europace meeting (23-26 June, Athens, Greece).
Cardiac Rhythm news for specialists

Multicentre European study set to evaluate HeartLight system for persistent atrial fibrillation

A study is to be the first to prospectively assess the outcomes of pulmonary vein isolation with balloon ablation catheters in patients with persistent atrial fibrillation, according to a company release.
Cardiac Rhythm news for specialists

Boston Scientific to acquire Bard EP

Boston Scientific has announced that it has entered into a definitive agreement to acquire Bard EP, the electrophysiology business of CR Bard, for US$275 million in cash. The company expects to close the transaction in the second half of 2013, subject to customary closing conditions.

John D Day

John D Day is the medical director at Intermountain Heart Rhythm Specialists, Utah, USA. He spoke to Cardiac Rhythm News about his career achievements, the atrial fibrillation ablation programme at the Intermountain Heart Institute, his research on atrial fibrillation and Alzheimer's disease.
Cardiac Rhythm news for specialists

What’s hot at EHRA Europace 2013

The European Society of Cardiology (ESC) has announced that this years' European Heart Rhythm Association (EHRA) Europace meeting will include, for the first time, late-breaking clinical trial sessions.
Cardiac Rhythm news for specialists

Contact force highlighted at HRS 2013

Endosense presented new study data validating the importance of several proprietary contact force parameters in cardiac ablation procedures, including its most recently developed Lesion Index (LSI), at Heart Rhythm 2013.
Cardiac Rhythm news for specialists

Renal denervation now under consideration for arrhythmias

Studies are exploring renal denervation as an adjunctive treatment in other diseases characterised by sympathetic overactivity such as ventricular arrhythmias, atrial fibrillation, metabolic syndrome and obstructive sleep apnoea. Cardiac Rhythm News spoke to leading physicians who are investigating this technology for the management of atrial fibrillation.
Cardiac Rhythm news for specialists

HeartLight system featured at German Cardiac Society Meeting

CardioFocus has announced that presentations of the HeartLight system and its role in the treatment of advanced atrial fibrillation were featured at the 79th Annual Meeting of the German Cardiac Society in Mannheim, Germany.